Document:

Share Purchase Agreement, dated as of December 5, 2006

 Exhibit 4.11 
 CGEN DIGITAL MEDIA COMPANY LIMITED 
 SERIES C PREFERRED SHARES 
 PURCHASE AGREEMENT 
 December 5, 2006 
  

 TABLE OF CONTENTS 
  

							
	 	  	 	  	 	  	Page
	 1.
	  	Terms of Purchase and Sale	  	1
				
		  	1.1	  	Restated Articles	  	1
				
		  	1.2	  	Purchase and Sale of Series C Preferred Shares	  	1
				
		  	1.3	  	The Closing	  	2
				
		  	1.4	  	Termination Date	  	2
			
	 2.
	  	Representations and Warranties of the Warrantors	  	2
				
		  	2.1	  	Organization Good Standing and Qualification	  	2
				
		  	2.2	  	Authorization	  	3
				
		  	2.3	  	Capitalization of the Company	  	3
				
		  	2.4	  	Subsidiaries	  	5
				
		  	2.5	  	Compliance with Other Instruments	  	6
				
		  	2.6	  	Consents	  	6
				
		  	2.7	  	Permits	  	6
				
		  	2.8	  	Litigation	  	6
				
		  	2.9	  	Patents and Other Intangible Assets	  	6
				
		  	2.10	  	Marketing Rights	  	8
				
		  	2.11	  	Agreements, Action	  	8
				
		  	2.12	  	Brokers or Finders	  	10
				
		  	2.13	  	No Conflict of Interest	  	10
				
		  	2.14	  	Rights of Registration	  	11
				
		  	2.15	  	Corporate Documents and Minute Books	  	11
				
		  	2.16	  	Title to Property and Assets	  	11
				
		  	2.17	  	Financial Statements	  	12
				
		  	2.18	  	Changes	  	13
				
		  	2.19	  	Employment Benefit Plans	  	14
				
		  	2.20	  	Tax, Tax Returns and Payments	  	14
				
		  	2.21	  	Insurance	  	15
				
		  	2.22	  	Labor Agreements and Actions	  	16
				
		  	2.23	  	Environmental and Safety Laws	  	16
				
		  	2.24	  	No Other Business	  	16

  

 -i- 

 TABLE OF CONTENTS 
 (continued) 
  

							
	 	  	 	  	 	  	Page
		  	2.25	  	Other Representations and Warranties Relating to WFOE and OpCo	  	16
				
		  	2.26	  	Disclosure and Accuracy of Information	  	17
				
		  	2.27	  	Reliance	  	17
				
		  	2.28	  	Warranties Separate and Independent	  	17
				
		  	2.29	  	Business Plan	  	17
				
		  	2.30	  	Transactions with Affiliates	  	18
				
		  	2.31	  	Compliance with Laws; FCPA	  	18
				
		  	2.32	  	Knowledge	  	18
			
	 3.
	  	Representations and Warranties of the Investor	  	18
				
		  	3.1	  	Due Incorporation and Valid Existence	  	18
				
		  	3.2	  	Authorization	  	18
				
		  	3.3	  	Purchase Entirely for Own Account	  	19
				
		  	3.4	  	Investment Experience	  	19
				
		  	3.5	  	No Public Market	  	19
				
		  	3.6	  	Compliance with Laws	  	19
				
		  	3.7	  	Exemption from Registration	  	19
			
	 4.
	  	Conditions to Investors’ Obligations at Closing	  	20
				
		  	4.1	  	Accuracy of Representations and Warranties	  	20
				
		  	4.2	  	Performance	  	20
				
		  	4.3	  	Compliance Certificate	  	20
				
		  	4.4	  	Qualifications and Consents	  	20
				
		  	4.5	  	Proceedings and Documents	  	20
				
		  	4.6	  	Opinion of Company Counsel	  	20
				
		  	4.7	  	Board of Directors	  	21
				
		  	4.8	  	Registration Rights Agreement	  	21
				
		  	4.9	  	Shareholders’ Agreement	  	21
				
		  	4.10	  	Officer’s Certificate	  	21
				
		  	4.11	  	No Material Adverse Change	  	21
				
		  	4.12	  	No Litigation	  	21
				
		  	4.13	  	Share Certificates	  	21

  

 -ii- 

 TABLE OF CONTENTS 
 (continued) 
  

							
	 	  	 	  	 	  	Page
		  	4.14	  	Employment Agreement	  	21
				
		  	4.15	  	Compensation Committee	  	21
				
		  	4.16	  	IP License Agreements	  	21
				
		  	4.17	  	Due Diligence	  	21
				
		  	4.18	  	Indemnification Agreement	  	22
				
		  	4.19	  	Financial Control Policies	  	22
				
		  	4.20	  	Conversion of Notes	  	22
				
		  	4.21	  	Exercise of Warrants	  	22
				
		  	4.22	  	CGEN Info	  	22
				
		  	4.23	  	Tax Indemnity Agreement	  	22
			
	 5.
	  	Conditions of the Company’s Obligations at Closing	  	22
				
		  	5.1	  	Representations and Warranties True at Closing	  	22
				
		  	5.2	  	Qualifications	  	23
				
		  	5.3	  	Covenants	  	23
				
		  	5.4	  	Registration Rights Agreement	  	23
				
		  	5.5	  	Shareholders’ Agreement	  	23
			
	 6.
	  	Affirmative Covenants of the Warrantors	  	23
				
		  	6.1	  	Accounting and Reserves; Funding Documentation	  	23
				
		  	6.2	  	Payment of Taxes and Claims	  	23
				
		  	6.3	  	Availability of Ordinary Shares for Conversion	  	23
				
		  	6.4	  	Governing Instruments	  	24
				
		  	6.5	  	Use of Proceeds	  	24
				
		  	6.6	  	Bank Signatories	  	24
				
		  	6.7	  	Intellectual Property; Change of Name	  	24
				
		  	6.8	  	FY 2007 Financial Statements	  	25
			
	 7.
	  	Miscellaneous Provisions	  	25
				
		  	7.1	  	Indemnity	  	25
				
		  	7.2	  	Inconsistent Agreements	  	25
				
		  	7.3	  	Survival	  	25
				
		  	7.4	  	Transfer of Successors and Assigns	  	25

  

 -iii- 

 TABLE OF CONTENTS 
 (continued) 
  

							
	 	  	 	  	 	  	Page
		  	7.5	  	Governing Law	  	26
				
		  	7.6	  	Dispute Resolution	  	26
				
		  	7.7	  	Counterparts	  	27
				
		  	7.8	  	Titles and Subtitles	  	27
				
		  	7.9	  	Notices	  	27
				
		  	7.10	  	Expenses	  	27
				
		  	7.11	  	Attorneys’ Fees	  	27
				
		  	7.12	  	Amendments and Waivers	  	28
				
		  	7.13	  	Severability	  	28
				
		  	7.14	  	Delays or Omissions	  	28
				
		  	7.15	  	Entire Agreement	  	28
				
		  	7.16	  	Further Assurances	  	28
				
		  	7.17	  	Specific Performance	  	28
				
		  	7.18	  	Understanding Among Investors	  	28
				
		  	7.19	  	Publicity	  	29
				
		  	7.20	  	Confidentiality and Non-Disclosure	  	29
				
		  	7.21	  	Investors’ Rights	  	31
			
	 8.
	  	Definitions	  	31
				
		  	8.1	  	Defined Terms	  	31
				
		  	8.2	  	Construction of Certain Terms and Phrases	  	35

  

 -iv- 

 SCHEDULES AND EXHIBITS 
  

			
	 Designation
	  	 Description

	Schedule I	  	Investors
		
	Schedule II	  	Schedule of Exceptions
		
	Schedule III	  	Particulars of the Company
		
	Schedule IV	  	Particulars of the Subsidiaries
		
	Schedule V	  	Leased Property
		
	Schedule VI	  	Key Employees
		
	Schedule VII	  	Convertible Notes
		
	Schedule VIII	  	Warrants
		
	Schedule IX	  	Notice Schedule
		
	Exhibit A	  	Form of the Third Amended and Restated Memorandum and Articles of Association
		
	Exhibit B	  	Form of Shareholders’ Agreement
		
	Exhibit C	  	Form of Registration Rights Agreement
		
	Exhibit D-1	  	Shareholders and Persons Holding Options, Warrants, etc. Immediately Prior to the Closing
		
	Exhibit D-2	  	Shareholders and Persons Holding Options, Warrants, etc. Assuming Completion of the Closing
		
	Exhibit E	  	Business Plan
		
	Exhibit F	  	Form of Opinion of Company’s Cayman Islands Counsel
		
	Exhibit G	  	Form of Opinion of Company’s PRC Counsel
		
	Exhibit H	  	Form of Employment Agreement
		
	Exhibit I	  	Form of Intellectual Property License Agreements

  

 i 

			
	Exhibit J	  	Form of Indemnification Agreement
		
	Exhibit K	  	Form of Intellectual Property Transfer Agreements
		
	Exhibit L	  	Form of Tax Indemnity Agreement

  

 ii 

 CGEN DIGITAL MEDIA COMPANY LIMITED 
 SERIES C PREFERRED SHARES 
 PURCHASE AGREEMENT 
 THIS SERIES C PREFERRED SHARES PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of December 5, 2006, by and among CGEN
Digital Media Company Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the “Company”), CGEN Media Technology Company Limited (“CGEN HK”), CGEN
Digital Technology (Shanghai) Co., Ltd. (GRAPHIC(GRAPHIC)GRAPHIC) (“WFOE”), a wholly foreign-owned enterprise organized under the laws of the People’s Republic of China, Shanghai CGEN Digital Media
Network Co., Ltd. (GRAPHIC), a domestic limited liability company registered in Shanghai, PRC (“OpCo”), Chan Yi Sing (Singapore NRIC No. S1306068A), Tian Guanyong (

) (PRC ID No. 133031651224065), Cao Xiaofeng (

) (PRC ID No. 310112197008270052), Yao Fang (

) (PRC ID No. 310221670521081) and Zhu Hai Guang (

) (PRC ID No. 410423197106070010) (together with Chan Yi Sing, Tian Guanyong (

), Cao Xiaofeng (

) and Yao Fang (

), the “Founders”, and each a “Founder”; and together with the Company, CGEN HK, WFOE, OpCo and the Founders, the “Warrantors” and each a
“Warrantor”), and each of the other parties listed on Schedule I hereto identified as an investor (each an “Investor” and collectively, the “Investors”). 
 RECITALS 
 WHEREAS, subject to the
terms and conditions of this Agreement, the Company desires to sell to the Investors, and the Investors desire to purchase from the Company, certain Series C Redeemable Convertible Preferred Shares of the Company, par value US$0.000001 per share
(the “Series C Preferred Shares”), which are convertible into the Company’s ordinary shares, par value US$0.000001 (the “Ordinary Shares” and, together with the Series C Preferred Shares, the
“Securities”). 
 IT IS HEREBY AGREED AS FOLLOWS: 
  

	1.	Terms of Purchase and Sale. 

  

	 	1.1	Restated Articles. 

 The Company shall adopt on or
before the date of the Closing (as defined below) the Third Amended and Restated Memorandum and Articles of Association in the form attached hereto as Exhibit A (the “Restated Articles”). The rights, preferences and
privileges of the Series C Preferred Shares will be as provided in the Restated Articles. 
  

	 	1.2	Purchase and Sale of Series C Preferred Shares. 

 Subject to the terms and conditions of this Agreement, each of the Investors agrees, severally and not jointly, to purchase from the Company at the Closing (as defined below), and 

  

 - 1 - 

 
the Company agrees to sell and issue to each of the Investors at the Closing (as defined below), that number of Series C Preferred Shares as is set forth
opposite such Investor’s name on Schedule I with the aggregate purchase price to be paid by each Investor for the Series C Preferred Shares to be acquired by such Investor at the Closing being as stated on Schedule I opposite such
Investor’s name. 
 1.3 The Closing. Subject to the satisfaction or waiver of all conditions with respect to the Closing as set
forth in this Agreement, the closing of the sale and purchase of the Series C Preferred Shares pursuant to this Agreement shall take place at the offices of O’Melveny & Myers LLP at 37th Floor, 1266 Nanjing Road West, Shanghai, on or
about December 8, 2006, or at such other time and place as the Company and the Investors may mutually agree (the “Closing”). At the Closing: 
 (i) the Company shall allot and issue to each Investor the number of Series C Preferred Shares set forth on Schedule I opposite
such Investor’s name, and deliver to such Investor share certificate(s) representing such Series C Preferred Shares. 
 (ii) each Investor shall pay such amount of purchase price as set forth on Schedule I opposite such Investor’s name, by wire transfer of immediately available funds into the Main Account (as defined in Section 6.6
below) for purchasing Series C Preferred Shares at US$0.20357356 per share. 
 1.4 Termination Date. If, as of December 31, 2006,
any of the conditions specified in Section 4 of this Agreement have not been fulfilled, each of the Investors shall, at its election, be relieved of all of its obligations under this Agreement. 
  

	2.	Representations and Warranties of the Warrantors. 

 Each Warrantor hereby represents and warrants jointly and severally to each Investor that, except as set forth on the Schedule of Exceptions attached hereto as Schedule II (the “Schedule of Exceptions”) (which
exceptions shall be deemed to be representations and warranties as if made hereunder), each of the matters set forth in this Section 2 is true and correct as at the date of this Agreement and as at the Closing, unless otherwise
specifically set forth below. 
 2.1 Organization Good Standing and Qualification. Schedule III sets out the full corporate
particulars of the Company. Schedule IV sets out full corporate particulars of each of the Subsidiaries and OpCo. The Company, the Subsidiaries and OpCo shall be collectively referred to as the “Group” and each a
“Group Company”, “member of the Group”, or “Group member”. The details of each member of the Group as set forth in Schedules III and IV are true and accurate. Each
member of the Group is duly organized, validly existing and in good standing (or equivalent status in the relevant jurisdiction) under, and by virtue of, the laws of the place of its incorporation or establishment and has the requisite corporate
power, right and authority to carry on its business as now conducted and as proposed to be conducted. Each member of the Group is duly qualified to transact business and is in good standing in each jurisdiction in which the failure so to qualify
could reasonably be expected to have a material adverse effect on its, or the Group’s business, operations, operating results, properties, assets, condition, liabilities or ability to perform any of its obligations under any Contracts
(“Material Adverse Effect”). 
  

 2 

 2.2 Authorization. Each Warrantor has all requisite corporate power to execute and deliver this
Agreement, to carry out and perform its obligations under this Agreement, to own, lease and operate its properties and to carry on its business as now conducted, and as proposed to be conducted. All corporate action on the part of each Group
Company, and its officers, directors and shareholders necessary for the authorization, execution and delivery of this Agreement, the Shareholders’ Agreement in the form attached hereto as Exhibit B (the “Shareholders’
Agreement”) and the Registration Rights Agreement in the form attached hereto as Exhibit C (the “Registration Rights Agreement”, together with the Restated Articles and the Shareholders’ Agreement,
the “Related Agreements”), the performance of all obligations of each Warrantor hereunder and thereunder and the authorization, issuance and delivery of the Series C Preferred Shares has been taken or will be taken prior to
the Closing, and this Agreement and the Related Agreements constitute valid and legally binding obligations of each Warrantor party hereto or thereto, enforceable against such Warrantor in accordance with their respective terms, except (i) as
limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, and other laws of general application affecting the rights of creditors generally, or as limited by laws relating to the availability of specific
performance, injunctive relief, or other equitable remedies, and (ii) to the extent the indemnification provisions contained in the Registration Rights Agreement may be limited by applicable securities laws. The Series C Preferred Shares, when
issued in compliance with the provisions of this Agreement, will be duly authorized, validly issued and will be fully paid and non-assessable and will have the rights, preferences and privileges described in the Restated Articles. The Ordinary
Shares issuable upon conversion of the Series C Preferred Shares have been duly authorized, duly and validly reserved and, when issued in compliance with the provisions of this Agreement and the Restated Articles will be duly authorized, validly
issued, fully paid and non-assessable. The Series C Preferred Shares, and the Ordinary Shares issuable upon the conversion of the Series C Preferred Shares, will be free of any liens, charges or encumbrances other than those created by or imposed
upon the holders thereof through no action of any Warrantor, and will be free of restrictions on transfer, other than the restrictions on transfer under this Agreement and the Related Agreements or under applicable securities laws. 
 2.3 Capitalization of the Company. 
 As at the date of this Agreement and immediately prior to the Closing, the authorized and issued capital of the Company is as set forth in Schedule III and Exhibit D-1. Immediately prior to the Closing, the authorized share
capital of the Company consists of: 
 (a) Preferred Shares. 120,000,000 Series C Preferred Shares, none of which is issued and
outstanding as of the date hereof; 130,000,000 Series B Redeemable Convertible Preferred Shares, par value US$0.000001 per share (the “Series B Preferred Shares”), of which 127,752,162 are issued and outstanding as of the
date hereof; 100,000,000 Series A Redeemable Convertible Preferred Shares, par value US$0.000001 per share (the “Series A Preferred Shares”), of which 43,685,079 are issued and outstanding as of the date hereof (Series A
Preferred Shares, Series B Preferred Shares and Series C Preferred Shares hereinafter being referred to as the “Preferred Shares”). The rights, privileges and preferences of the Preferred 

  

 3 

 
Shares are as stated in the Restated Articles. Assuming purchase and subscription in full of all Series C Preferred Shares available for purchase and
subscription at the Closing under this Agreement, the share capital of the Company (including without limitation issued shares, shares authorized for issuance and shares issuable upon exercise of authorized optional or convertible securities)
immediately after the Closing is set forth in the capitalization table in D-2. 
 (b) Ordinary Shares. 580,000,000 Ordinary
Shares, par value US$0.000001 per share, of which 100,000,000 are issued and outstanding. Of the total authorized Ordinary Shares, 150,000,000 shall be reserved for issuance upon conversion of issued and outstanding Series C Preferred Shares,
150,000,000 shall be reserved for issuance upon conversion of issued and outstanding Series B Preferred Shares, 110,000,000 shall be reserved for issuance upon conversion of issued and outstanding Series A Preferred Shares, and 25,000,000 shall be
reserved for issuance to employees, officers, directors, consultants or advisers to, the Company or any subsidiary of the Company pursuant to incentive agreements, option plans, share bonuses or awards, warrants or other arrangements approved by the
Board of Directors of the Company and as may be approved from time to time by the Investors pursuant to the Shareholders’ Agreement. 
 (c) Issued Shares. A true and complete list of (x) the Company’s shareholders and their holdings and (y) those Persons holding options, warrants or other rights to purchase any class of the Company’s share capital
(excluding conversion privileges of the Preferred Shares) and their holdings, prior to the issuance of the Series C Preferred Shares purchased hereunder and assuming the issuance of all Series C Preferred Shares purchased at the Closing hereunder is
set forth in Exhibits D-1, and D-2 respectively to this Agreement. All of the issued and outstanding shares of the Company as of the Closing are duly authorized, validly issued, fully paid and non-assessable and were issued in
compliance with applicable Law. The Series C Preferred Shares have been duly authorized, and when issued, sold, and delivered in accordance with the terms of this Agreement, will be duly and validly issued, fully-paid and non-assessable, will be
issued in compliance with all applicable Law, and will be free of any preemption or similar rights or Encumbrance other than as contemplated by the Related Agreements. The Ordinary Shares issuable upon the conversion of the Series C Preferred Shares
in accordance with the Restated Articles, have been duly authorized, and upon issuance in connection with such conversion, will be duly and validly issued, fully-paid and non-assessable, will be issued in compliance with all applicable securities
laws, and will be free of any preemption or similar rights or Encumbrances other than as contemplated by the Related Agreements. 
 (d)
Voting and Other Agreements. Except for the Preferred Shares, and options granted under the Company’s ESOP Plans, there are no outstanding options, warrants, rights (including conversion or preemptive rights) or agreements, orally or in
writing, for the purchase, redemption or acquisition from the Company of any shares of its share capital. Except as otherwise contemplated herein, the Company is not a party or subject to any agreement or understanding, and, to the Knowledge of the
Warrantors, there is no agreement or understanding between any Persons that affects or relates to (A) the voting or giving of written consents with respect to any security of the Company (including, without limitation, any voting agreements,
voting trust agreements, shareholder agreements or similar agreements) or the voting by a director of the Company or (B) the sale, transfer or other disposition with respect to any security of the Company. 
  

 4 

 2.4 Subsidiaries. The Company does not currently own or control, directly or indirectly, any
interest in any other Person other than in a member of the Group. No Persons other than the Company or WFOE holds any option, warrant or other right to purchase any class of any share capital of any of the members of the Group. All of the issued and
outstanding shares of each of the members of the Group are duly authorized, validly issued, fully paid and non-assessable and were issued in compliance with applicable securities laws. 
 (a) Capitalization of CGEN HK. 
 (i). The Company is the sole legal and beneficial shareholder of CGEN HK. 
 (ii). There are
no outstanding rights of first refusal, preemptive rights or other rights, warrants, options, conversion privileges, subscriptions, or other agreements or securities, either directly or indirectly, entitling the holder thereof to purchase or
otherwise acquire or to compel CGEN HK to increase or decrease its authorized or issued share capital or to issue, repurchase or redeem any of such capital. 
 (b) Capitalization of WFOE. 
 (i). Registered Capital. The registered capital
of WFOE has been fully funded by CGEN HK in accordance with the terms of WFOE’s articles of association. CGEN HK is the sole legal and beneficial holder of all of the equity interest of WFOE. Such capitalization of WFOE and the ownership of
WFOE by CGEN HK have been approved by all relevant PRC authorities, which approvals are in full force and effect and have not lapsed or been revoked. 
 (ii). Other Securities. There are no outstanding rights of first refusal, preemptive rights, or other rights, warrants, options, conversion privileges, subscriptions, or other rights, agreements or securities,
either directly or indirectly, entitling the holder thereof to purchase or otherwise acquire or to compel WFOE to increase or decrease WFOE’s registered capital. 
 (c) Capitalization of OpCo. 
 (i). All of the registered capital of OpCo has been paid
in full. 
 (ii). GAO Weiming (GRAPHIC) holds 49.5 % of record, CAO Xiaofeng (

) holds 18% of record, YAO Fang (

) holds 13.5% of record, TIAN Guanyong (

) holds 10% of record and ZHU Haiguang (

) holds 9% of record, respectively, of the equity interest in OpCo, as at the date hereof. 
 (iii). The Persons identified in paragraph (ii) are the only Persons with direct or indirect interests in the equity capital of OpCo, and each such Person holds its respective interests in OpCo free and clear of any Encumbrances,
except as provided under the call option agreement dated January 16, 2006 among WFOE, OpCo and the shareholders of OpCo (the “OpCo Call Option”). None of such Persons will transfer, alienate or dispose of any direct or
indirect interest in OpCo or create any Encumbrance over any such interest except as required pursuant to this Agreement or OpCo Call Option. 
  

 5 

 (iv). Except pursuant to OpCo Call Option, there are no outstanding rights of first
refusal, preemptive rights or other rights, warrants, options, conversion privileges, subscriptions, or other agreements or securities, either directly or indirectly, entitling the holder thereof to purchase or otherwise acquire or to compel OpCo to
increase or decrease its registered capital or to issue, repurchase or redeem any of such registered capital or its issued capital. 
 2.5
Compliance with Other Instruments. No member of the Group is in violation or default of any provisions of (i) its Articles and Memorandum of Association (or equivalent charter documents) or (ii) any Contract or of any judgment,
order, writ, decree, statute, rule or regulation applicable to such member of the Group, except where any such violation or default could not reasonably be expected to result in (x) the Group member’s loss of any right granted under any
Contract or (y) a Material Adverse Effect. The execution, delivery and performance of this Agreement, the Related Agreements and the consummation of the transactions contemplated hereby and thereby will not result in any violation, or
constitute a default, by any member of the Group under any such Contract, judgment, order, writ, decree, statute, rule or regulation or an event that results in the creation of any Encumbrance upon any assets of any member of the Group whether with
or without the passage of time or the giving of notice, or both. 
 2.6 Consents. No consent, approval, license, order or
authorization of, or registration, qualification, designation, declaration or filing with, any Governmental Authority or any party to a Contract or any other third party (each a “Consent”) is required by any Warrantor in
connection with (x) the valid execution and delivery of this Agreement and the Related Agreements, (y) the offer and sale of the Securities or (z) the consummation of the transactions contemplated by this Agreement and the Related
Agreements, except such filings as may be required under applicable securities laws of the United States, which filings will be timely filed within the applicable periods therefore. 
 2.7 Permits. Each member of the Group has all franchises, permits, licenses and any similar authority (each a “Permit”) as
necessary for the conduct of its business as now being conducted by it, except for those Permits the failure of which to obtain could not reasonably be expected to have a Material Adverse Effect. No member of the Group is in material default under
any Permit. The execution, delivery and performance of and compliance with this Agreement and Related Agreements and the issuance of the Securities will not result in suspension, revocation, impairment, forfeiture or non-renewal of any Permit that
could reasonably be expected to result in a Material Adverse Effect. 
 2.8 Litigation. There is no action, suit, proceeding or
investigation pending or, to the Knowledge of each Warrantor, currently threatened against any member of the Group or any of their respective properties nor to the Knowledge of any Warrantor is there any basis for the foregoing, including, without
limitation, any action, suit, proceeding or investigation that questions the validity of this Agreement or any Related Agreement or any action to be taken in connection herewith or therewith. No member of the Group or any of their respective
properties is a party or subject to the provisions of any order, writ, injunction, judgment or decree of any Governmental Authorities. There is no action, suit, proceeding or investigation by any member of the Group currently pending or which any
member of the Group currently intends to initiate. 
 2.9 Patents and Other Intangible Assets. 
  

 6 

 (a) All patents and patent rights, entity models, trademarks and trademark rights, trade names and trade
name rights, service marks and service mark rights, service names and service name rights, brand names, internet domain names and sub-domains, inventions, processes, formulas, copyrights and copyright rights, trade dress, business and product names,
logos, slogans, trade secrets, industrial models, processes, designs, methodologies, computer programs (including all source codes), license rights to use packaged software and related documentation, technical information, manufacturing, engineering
and technical drawings, know-how and all pending applications for and registrations of patents, entity models, trademarks, service marks, copyrights and internet domain names and sub-domains (collectively, “Intellectual
Property”) used in the business or businesses of any member of the Group: 
 (i) is owned by the Company or
relevant member of the Group as the sole legal and beneficial owner, free of any license or Encumbrance in favor of any other Person (the “Group’s Intellectual Property”); or 
 (ii) is used by the Group in accordance with the terms of a current license from the owner of that Intellectual Property
(“Licensed IP”). 
 (b) Each of the Group’s Intellectual Property that is material to the business or businesses
of any member of the Group is set forth in Section 2.9(c) of Schedule II. 
 (c) None of the Group’s Intellectual
Property has been wrongfully or unlawfully acquired by the Group. Each of the registrations (and applications therefor) of the Group’s Intellectual Property is valid. Neither any member of the Group nor any other Person has breached or alleged
a breach of any of the licenses under the Licensed IP during the six years preceding the date of this Agreement. The Group’s Intellectual Property, and the validity or subsistence of the Group’s right, title and interest therein, is not
the subject of any current, pending or threatened challenge, claim or proceedings, including for opposition, cancellation, revocation or rectification, and has not during the periods of six years prior to the Closing been the subject of any
challenge, claim or proceeding, and to the Knowledge of each Warrantor there are no facts or matters that might give rise to any such challenge, claim or proceeding. The Group has taken commercially reasonable efforts to preserve the Group’s
Intellectual Property and without limitation, all renewal fees regarding the Group’s Intellectual Property due on or before the Closing have been paid in full. No member of the Group has entered into any agreement, arrangement or understanding
(whether legally enforceable or not) for the licensing, or otherwise permitting the use or exploitation, of the Group’s Intellectual Property or that prevents, restricts or otherwise inhibits the Group’s freedom to use and exploit the
Group’s Intellectual Property. To the Knowledge of each Warrantor, none of the Group’s Intellectual Property is currently being infringed by any third party or has been so infringed during the six-year periods preceding the Closing and no
third party has threatened any such infringement. No third party has, during the two years preceding the date of this Agreement made, threatened or brought any challenge, claim or proceedings in relation to the Group’s use of the Licensed IP
(and to each Warrantor’s Knowledge there are no facts or matters that might give rise to any such challenge, claim or proceedings). The carrying on of the Group’s business or businesses as presently constituted does not require any
licenses or consents from (except for standard end-user agreements with respect to commercially readily available intellectual property such as “off the shelf” computer software and for Licensed IP), or the making of royalty or similar
payments 

  

 7 

 
to, any third party, and to the Knowledge of the Warrantors no member of the Group uses or needs to use any processes or is engaged in any activities that
infringe any Intellectual Property belonging to any third party and no member of the Group has within the six years preceding this Agreement used any Intellectual Property in a way that has infringed or infringes the Intellectual Property rights of
a third party. No Warrantor has any Knowledge that that any employees of any Group member is obligated under any contract (including licenses, covenants or commitments of any nature) or other agreement, or subject to any judgment, decree or order of
any court, that would interfere with the use of such employees’ best efforts to promote the interest of the Group or that would conflict with the Group’s business as conducted. Neither the execution nor delivery of this Agreement, nor the
carrying on of the Group’s business by the employees of the Group as conducted will, to the Knowledge of each Warrantor, conflict with or result in a breach of the terms, conditions, or provisions of, or constitute a default under, any
contract, covenant or instrument under which any such employee is now obligated. To the Knowledge of each Warrantor, it is not and will not be necessary to use any inventions of any of employees of any Group member (or persons it currently intends
to hire) made prior to their employment with the Group. Each Founder and each officer or employee of any Group Company who has developed any Intellectual Property in the course of his or her employment or service with the Group has, where necessary,
validly assigned to the Company or WFOE all rights, title and interest that he or she may have in or to any such Intellectual Property. 
 (d) No member of the Group has entered into any agreement, other than as set forth on Section 2.9(d) of Schedule II and provided to the Investors or their counsel, to indemnify any other person against any charge of
infringement or misappropriation of any Group’s Intellectual Property. 
 (e) Each Group Company has taken all reasonably necessary
action to protect and preserve (i) the validity and enforceability of trade and service marks and associated goodwill included in the Group’s Intellectual Property; (ii) the enforceability of copyrights and the confidentiality,
validity and enforceability of pending patent applications included in the Group’s Intellectual Property; (iii) the validity and enforceability of patents included in the Group’s Intellectual Property; and (iv) the
confidentiality and enforceability of trade secrets and the confidentiality of other proprietary information included in the Group’s Intellectual Property. 
 (f) There is no agreement pursuant to which any current or former employee or consultant of any Group Company has rights to any part of the Group’s Intellectual Property. 
 2.10 Marketing Rights. No member of the Group has granted rights to market or sell its products to any other Person and no member of the Group is
bound by any agreement that affects any such member of the Group’s exclusive right to market or sell its products. 
 2.11
Agreements, Action. 
 (a) Save as disclosed in Section 2.11 of Schedule II, neither the Company nor any member of
the Group is a party to or bound by: 
 (i) any Contract, judgment, order, writ or decree under which it has borrowed any
money or issued any note, bond, debenture or other evidence of indebtedness, or any 

  

 8 

 
mortgage, pledge, security agreement, deed of trust, financing statement or other document granting any lien, encumbrance or security interest (including
liens, encumbrances or security interests upon properties acquired under conditional sales, capital leases and other title retention or security devices), or any guaranty or endorsement (other than endorsements for collection in the ordinary course
of business) of, or other contingent obligations in respect of, indebtedness for borrowed money or other liabilities or obligations of others, in any separate case in excess of US$150,000 in principal amount or US$300,000 in the aggregate;

 (ii) any Contract, judgment, order, writ, decree, commitment, arrangement or understanding relating to any joint venture,
partnership or sharing of profits or losses with any Person or entity or permitting any Person or entity to use any technology, know-how or proprietary information of the Company; 
 (iii) any Contract, instrument, judgment, order, writ, decree, commitment for the future purchase by any member of the Group of any
materials, equipment, services or supplies that (A) involves the payment of more than US$150,000, (B) continues for a period of more than twelve months, (C) by its terms requires the Company to purchase the entire output or services
of a supplier or (D) provides that any supplier will be the exclusive supplier of the Group; 
 (iv) any Contract,
instrument, judgment, order, writ or decree for the sale or other disposition by the Group of its assets or properties other than in the ordinary course of business, or for the merger, or consolidation of any member of the Company with any other
Person; 
 (v) any Contract, instrument, judgment, order, writ or decree containing covenants purporting to limit the freedom
of the Group to compete in any line of business or in any geographic area; 
 (vi) any Contract, instrument, judgment, order,
writ or decree not elsewhere specifically disclosed pursuant to this Agreement involving the payment or receipt by any member of the Group of more than US$100,000 per year or US$250,000 over the term thereof; 
 (vii) any Contract with a consultant which provides for payment during the term of the Contract of more than US$50,000; 
 (viii) any Contract with any employee of the Group that provides for payment of US$50,000 or more per annum; 
 (ix) any sale or purchase option or similar contract or arrangement affecting any assets owned or used by any Group Company or by which
any Group Company is bound; or 
 (x) any agreements restricting the freedom of any member of the Group to provide and take
goods and services or to manage its own business affairs by such means and from and to such persons as it may from time to time think fit. 
  

 9 

 (b) Other than as required by this Agreement, the Related Agreements and the Contracts identified in
Section 2.11 of Schedule II, (i) no Group Company has entered into any agreement with, or given any undertaking or assurance to, any of the existing shareholders of the Company or their affiliates, and (ii) there are no
agreements binding on the Company which prohibit or restrict the sale, disposal or transfer of any equity securities (or any interests therein) owned by the Company. 
 (c) True and complete copies of all Contracts identified in Section 2.11 of Schedule II (collectively, the “Scheduled Contracts”) have been provided to counsel for the
Investors. The Company has not received any notification of any breach, or default under any of the Scheduled Contracts. 
 (d) No member of
the Group has (i) declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its share capital, (ii) other than as expressly set forth in the Financial Statements (as defined below
in Section 2.17), and other than pursuant to the Convertible Notes, incurred any indebtedness for money borrowed or incurred any other liabilities individually in excess of US$50,000 or in excess of US$100,000 in the aggregate,
(iii) made any loans or advances to any Person or entity other than ordinary advances for travel expenses for employees in the ordinary course of business, or (iv) sold, exchanged or otherwise disposed of any of its assets or rights other
than in the ordinary course of business and at arm’s length. 
 (e) No member of the Group is a party to or bound by any Contract, or
subject to any restriction under its memorandum and articles of association or other constitutional documents that will have a Material Adverse Effect. 
 2.12 Brokers or Finders. Except as set forth on in Section 2.12 of Schedule II, no member of the Group has incurred, and will not incur, directly or indirectly, as a result of any action
taken by the Company, any liability for brokerage or finders’ fees or agents’ commissions or any similar charges in connection with this Agreement and the Related Agreements. 
 2.13 No Conflict of Interest. Except as described in the Financial Statements, no member of the Group is indebted, directly or indirectly, to any
of its officers, directors or shareholders in any amount whatsoever other than in connection with expenses or advances of expenses incurred in the ordinary course of business. None of the officers, directors or shareholders of any member of the
Group is indebted to such member of the Group, or any other member of the Group or, to each Warrantor’s Knowledge, have any direct or indirect ownership interest in any firm or corporation with which any member of the Group is affiliated or
with which any member of the Group has a business relationship, or any firm or corporation that competes with the Group. No member of the Group is a guarantor or indemnitor of any indebtedness of any other Person. None of the officers, directors or
shareholders of any member of the Group is directly or indirectly interested in any Contract with a member of the Group. None of the officers, directors or shareholders of any member of the Group or any affiliate of any such Person has had, either
directly or indirectly, any interest in (a) any Person that purchases from or sells, licenses or furnishes to a member of the Group any goods, property, proprietary assets, Intellectual Property or other property rights or services; or
(b) any Contract or agreement to which a member of the Group is a party or by which it may be bound or affected. 
  

 10 

 2.14 Rights of Registration. Except as contemplated in the Registration Rights Agreement, at the
time of Closing no member of the Group will be obligated to grant to any Person any registration rights, including piggyback rights, that are pari passu or senior to the registration rights to be granted pursuant to the Registration Rights
Agreement. 
 2.15 Corporate Documents and Minute Books. The copy of the minute books of the Company provided to the counsel for the
Investors contains minutes of all meetings of directors (including committees thereof) and shareholders and all actions by written consent without a meeting by the directors and shareholders since the date of incorporation and reflects all actions
by the directors (and any committee of directors) and shareholders with respect to all transactions referred to in such minutes accurately in all material respects. Each Group Company has properly kept all books, records and registers required to be
kept by it under any applicable Law, except to the extent that any failure to do so would not have a Material Adverse Effect. Each Group Company has filed or delivered all material returns, particulars, resolutions and other documents required to be
filed with or delivered to any Governmental Authority in respect of such Group Company. 
 2.16 Title to Property and Assets.
(a) Each member of the Group owns its property and assets free and clear of all Encumbrances, except such Encumbrances that arise in the ordinary course of business and do not materially impair such member of the Group’s ownership or use
of such property or any assets. With respect to the property and assets it leases, including the leased property described on Schedule V, the relevant member of the Group is in compliance in all material respects with such leases and, to each
Warrantor’s Knowledge, holds a valid leasehold interest free of any material liens, claims, loans or encumbrances and is in compliance with such leases. 
 (b) Each member of the Group owns or has a valid right to use all its property and assets necessary for its business as now conducted, including the leased property described on Schedule V, and, to the
Knowledge of each Warrantor, without any infringement of the rights of others. There are no outstanding options, licenses or agreements of any kind granted by any member of the Group relating to any of its property or assets, nor is any member of
the Group bound by or a party to any options, licenses or agreements of any kind with respect to any of the property or assets of any other Person except, in either case, for standard end-user agreements with respect to commercially readily
available intellectual property such as “off the shelf” computer software and the Licensed IP. 
 (c) Except as would not have a
Material Adverse Effect, the assets owned, possessed or used by the Group comprise all the assets required to enable the Group to carry on its business in the ordinary course. 
 (d) No debt owed to any Group member is more than three months overdue for payment. No Group member has released any debt on terms permitting the debtor
thereunder to pay less than the book value of the debt, and no debt owing to any Group member has been deferred, subordinated or written off or is reasonably believed to be unrecoverable. 
  

 11 

 2.17 Financial Statements. 
 (a) The Company has delivered to the Investors the Group’s audited consolidated financial statements (x) as of and for the 12 months ended
December 31, 2004 and (y) as of and for the 12 months ended December 31, 2005, in each case as audited by Ernest &Young, (collectively the “Financial Statements”). The Financial Statements truly and fairly
present in all material respects the financial condition and operating results of the Company as of the dates, and for the periods, indicated therein. Except as set forth in the Financial Statements, neither the Company nor any other member of the
Group has any liabilities, contingent or otherwise, other than (i) liabilities incurred in the ordinary course of business and at arm’s length subsequent to the December 31, 2005 (the “Audited Balance Sheet
Date”) and (ii) obligations under contracts and commitments incurred in the ordinary course of business and at arm’s length, which, in both cases, individually or in the aggregate would not have a Material Adverse Effect.

 (b) The Company has delivered to the Investor the Group’s unaudited consolidated management accounts as of and for the 9 months ended
September 31, 2006 (the “Management Accounts”). The Management Accounts truly and fairly present in all material respects the financial condition and operating results of the Company as of the dates, and for the periods,
indicated therein. Except as set forth in the Management Account, neither the Company nor any other member of the Group has any liabilities, contingent or otherwise, other than (i) liabilities incurred in the ordinary course of business and at
arm’s length subsequent to the September 30, 2006 (the “Unaudited Management Account Date”) and (ii) obligations under contracts and commitments incurred in the ordinary course of business and at arm’s
length, which, in both cases, individually or in the aggregate would not have a Material Adverse Effect. 
 (c) Full disclosure of and
adequate provisions for bad and doubtful debts and all liabilities, actual, contingent or otherwise and of all financial commitments in existence at the Audited Balance Sheet Date or Unaudited Management Account Date have been made in the Financial
Statements or the Management Accounts, as applicable. 
 (d) The results shown by the Financial Statements or the Management Accounts, as the
case may be, have not (save as therein disclosed) been affected by an extraordinary or exceptional or non-recurring item or by any other circumstances rendering the profits or losses for the period covered by the Financial Statements or the
Management Accounts, as the case may be, unusually high or low. 
 (e) The Financial Statements or the Management Accounts, reserve or
provide in full for all Taxation for which the Group was at the Audited Balance Sheet Date or the Unaudited Management Account Date, as applicable, liable, and whether or not the Group has or may have any right of reimbursement against any other
Person, the Financial Statements and the Management Accounts, as applicable, have provided for in full for any contingent or deferred liability to Taxation. 
 (f) None of the Group’s assets has been acquired for any consideration in excess of its net realizable value at the date of such acquisition or otherwise than by way of a bargain at arm’s length. 

(g) The rates of depreciation adopted in the Financial Statements or the Management Accounts were sufficient for each fixed asset of the Group to be
written down to nil by the end of its useful life. 
  

 12 

 (h) The Financial Statements have been prepared in accordance with the International Financial Reporting
Standards (as promulgated from time to time by the International Accounting Standards Board) on a consistent basis (“IFRS”). 
 (i) The Management Accounts have been prepared in accordance with the disclosed accounting policies of the Group and on a consistent basis as those used in the audited accounts and show a fair view of the assets and
liabilities, profits and losses of the Group as at and to the Unaudited Management Account Date. 
 2.18 Changes. Since Audited
Balance Sheet Date, save for transactions contemplated by this Agreement or as set forth in Section 2.18 of the Schedule of Exceptions, there has not been: 
 (a) any change in the business, assets, properties, liabilities, condition or operating results of the Group from that reflected in the Financial Statements, except changes in the ordinary course of business that
could not result in a Material Adverse Effect; 
 (b) any damage, destruction or loss, whether or not covered by insurance, materially and
adversely affecting the business, assets, properties, liabilities or condition or operating results of the Group; 
 (c) any waiver (or
partial waiver) or compromise by any member of the Group of a valuable right or of a material debt owed to it; 
 (d) any satisfaction or
discharge of any lien, claim or encumbrance or payment of any obligation by any member of the Group, except in the ordinary course of business that is not material to the business, properties or condition of such member of the Group; 
 (e) any material change to a Contract entered into by any member of the Group; 
 (f) any change in any compensation arrangement or agreement with any key employees set forth in Schedule VI; 
 (g) any sale, disposition, assignment or transfer of Group’s Intellectual Property; 
 (h) any sale, disposition, assignment or transfer of any tangible assets of the Group, except in the ordinary course of business; 
 (i) any resignation or termination of employment of any officer or key employee of the Group and there is no impending resignation or termination of
employment of any director, officer or employee of any Group member that, if consummated, is likely to have a Material Adverse Effect; 
  

 13 

 (j) receipt of notice that there has been a loss of, or order cancellation by, any major customer of any
member of the Group or cancellation or discontinuance by any major supplier or service provider of any member of the Group; 
 (k) any
mortgage, pledge, transfer of a security interest in, or lien, created by any member of the Group with respect to any of its properties or assets, except liens for taxes not yet due or payable; 
 (l) any payment, loan, advance or guaranty made by any member of the Group to, or any sale, transfer or lease of any properties or assets by any member
of the Group or any other agreement or arrangement entered into by any member of the Group with or for the benefit of, its employees, officers, directors or shareholders other than travel advances to employees or directors made in the ordinary
course of its business consistent with past practice; 
 (m) any declaration, setting aside or payment or other distribution in respect to
any of the share capital of any member of the Group, or any direct or indirect redemption, purchase or other acquisition of any of such share capital by any member of the Group; 
 (n) any change in the line of business of any member of the Group; 
 (o) any debt, obligation (other than contracts with the Group’s customers in the ordinary course of business), or liability incurred, assumed or guaranteed by any member of the Group individually in excess of
US$50,000; or 
 (p) any arrangement or commitment by any member of the Group to do any of the above items described in this
Section 2.18. 
 2.19 Employment Benefit Plans. No member of the Group is a party to or bound by any currently effective
employment contract, deferred compensation arrangement, bonus plan, incentive plan, profit sharing plan, retirement agreement or other employee or consultant compensation plan or agreement. No employee of any member of the Group has been granted the
right to continued employment by such member of the Group or to any material compensation following termination of employment with such member of the Group. 
 2.20 Tax, Tax Returns and Payments. 
 (a) Each member of the Group has filed or caused to be filed
all required Tax Returns (as defined below) with the appropriate Governmental Authorities in all jurisdictions in which such Tax Returns are required to be filed by each member of the Group and all Taxes (as defined below) shown on such Tax Returns
payable by such entity have been properly accrued or paid to the extent such Taxes have become due or are being contested in good faith, and for which reserves therefor have been established by the Group in accordance with IFRS. No member of the
Group has executed any waiver or extensions of any statute of limitations on the assessment or collection of any Tax or with respect to any liability arising therefrom. None of the income Tax Returns for any member of the Group has been audited by
any taxing authority. To the Knowledge of each Warrantor, no member of the Group is or expects to be involved in any dispute in relation to Tax and there is no relevant Governmental Authority concerned which has investigated or indicated that it
intends to investigate the Tax affairs of any member of the Group. 
  

 14 

 (b) The provisions for Taxes in the respective Financial Statements are sufficient for the payment of all
accrued and unpaid applicable Taxes of the relevant member of the Group, whether or not assessed or disputed as of the date of each such balance sheet. There have been no examinations or audits of any Tax Return by any applicable Governmental
Authority, except during routine annual inspection of the members of the Group incorporated in the PRC by the relevant PRC Governmental Authorities nor has any such Governmental Authority notified any Group member of its intention to do so. Since
Audited Balance Sheet Date, none of the members of the Group has incurred any Taxes other than in the ordinary course of business and each member of the Group has made adequate provisions on its books of account for all Taxes with respect to its
business, properties and operations for such period. No member of the Group has entered into or been engaged in or been a party to any transaction or series of transactions or scheme or arrangement of which the main or dominant purpose or one of the
main or dominant purposes was the avoidance or deferral of or reduction in the liability to Tax of such member of the Group. No tax scheme in effect, as previously applied in the Financial Statements has been illegal under any applicable Law.

 (c) To the Knowledge of each Warrantor, no member of the Group is, or has ever been, or will become, as a result of the transactions
contemplated hereunder or under the Related Agreements, a passive foreign investment company (“PFIC”) or a “controlled foreign corporation” (“CFC”), in each case, as defined in the Internal
Revenue Code of 1986, as amended (the “Code”). The Company and each member of the Group do not currently anticipate that any will become a PFIC or CFC for the current taxable year or any future taxable year. 
 (d) To the Knowledge of each Warrantor, the Company and each member of the Group are treated as a corporation for U.S. federal income tax purposes. No
election has been made under United States Treasury Regulation Section 301.7701-3 to treat the Company or any member of the Group as a partnership or disregarded entity for U.S. tax purposes. 
 2.21 Insurance. Each member of the Group has in full force and effect insurance policies in amounts customary for companies similarly situated and
nothing has been done or omitted to be done by or on behalf of such member of the Group that would make any policy of insurance void or voidable or enable the insurers to avoid the same and there is no claim outstanding under any such policy and to
the Knowledge of each Warrantor there are no circumstances likely to give rise to such a claim or result in an increased rate of premium. All information furnished in obtaining or renewing the insurance policies of any member of the Group was
accurate in all material respects when given and any change in that information required to be given was correctly given in all material respects. No member of the Group is in default under any of these policies or suffered any uninsured losses or
waived any rights of material or substantial value or allowed any insurance to lapse. No Group member has been refused any insurance coverage sought or applied for, and the Company has not been notified in writing that it will be unable to renew its
existing insurance coverage. 
  

 15 

 2.22 Labor Agreements and Actions. No member of the Group is bound by or subject to any written or
oral, express or implied, contract, commitment or arrangement (including, without limitation, collective bargaining agreements) with any labor union, and no labor union has requested or, to the Knowledge of each Warrantor, has sought to represent
any of the employees, representatives or agents of any member of the Group. There is no strike or other labor dispute involving any member of the Group pending, or to the Knowledge of each Warrantor, threatened, that could reasonably be expected to
have a Material Adverse Effect. Each member of the Group has complied in all material respects with all applicable Law related to employment. No member of the Group has engaged in any unfair labor practice that could reasonably be expected to result
in a Material Adverse Effect. No member of the Group has a present intention to terminate the employment of any officer or key employee, or any group of key employees. 
 2.23 Environmental and Safety Laws. To each Warrantor’s Knowledge, no member of the Group is in violation in any material respect with any applicable Law relating to the environment or occupational health
and safety that would have a material adverse effect on its employees, and to the Knowledge of each Warrantor, no material expenditures are or will be required in order to comply with any such existing Law. 
 2.24 No Other Business. The Company was formed solely to acquire and hold an equity interest in CGEN HK and WFOE (indirectly through its ownership
of CGEN HK). Since their formation, the Company and CGEN HK have not engaged in any business and have not incurred any liability except in the ordinary course of their business of acquiring and holding the equity interest of CGEN HK and WFOE,
respectively. 
 2.25 Other Representations and Warranties Relating to WFOE and OpCo. 
 (a) The constitutional documents and certificates and related material Contracts of WFOE and OpCo are valid and have been duly approved or registered (as
applicable) by competent PRC Governmental Authorities. 
 (b) All material consents, approvals, authorizations or licenses requisite under
the PRC Law for the due and proper establishment and operation of WFOE and OpCo have been duly obtained from the relevant PRC Governmental Authorities and are in full force and effect. 
 (c) All filings and registrations with the PRC Governmental Authorities required in respect of WFOE and OpCo and its operations including, without
limitation, the registrations with Ministry of Commerce, State Administration of Industry and Commerce, State Administration for Foreign Exchange, tax bureau and customs authorities have been duly completed in accordance with the relevant PRC rules
and regulations. 
 (d) Each of WFOE and OpCo has complied with all relevant PRC Law regarding the contribution and payment of its registered
share capital, the payment schedule of which has been approved by the relevant PRC Government Authorities. There are no outstanding rights of, or commitments made by any member of the Group to sell any equity interest in WFOE or OpCo, as applicable.

 (e) Each of WFOE and OpCo is not in receipt of any letter or notice from any relevant PRC Governmental Authority notifying it of
revocation of any licenses issued to it for non-compliance or the need for compliance or remedial actions in respect of the activities carried out by WFOE or OpCo as the case may be. 
  

 16 

 (f) Each of WFOE and OpCo has conducted its business activities within the permitted scope of business or
has otherwise operated its business in material compliance with all relevant legal requirements and with all requisite licenses and approvals granted by competent PRC Governmental Authorities. 
 (f) As to licenses and approvals requisite for the conduct of any part of WFOE’s or OpCo’s, as applicable, business which are subject to
periodic renewal, no Warrantor has any Knowledge of any grounds on which such requisite renewals will not be granted by the relevant PRC Governmental Authorities. 
 (g) With regard to employment and staff or labor, each of OpCo and WFOE has complied with all applicable PRC Law in all material respects, including without limitation, Law pertaining to welfare funds, social
benefits, medical benefits, insurance, retirement benefits, pensions or the like. 
 2.26 Disclosure and Accuracy of Information. Each
Warrantor has fully provided the Investors with all the relevant information that the Investors (or their counsel) have requested for deciding whether to subscribe for the Series C Preferred Shares and all information necessary to enable a
reasonable investor to make a fully informed decision as to whether or not to subscribe for the Series C Preferred Shares. All information contained in this Agreement (including the Recitals, Exhibits and the Schedules) and the other documents
referred to herein (except such information as provided by the Investors) and the Related Agreements is true, accurate and complete in all respects and not misleading in any respect. 
 2.27 Reliance. The Warrantors acknowledge that the Investors have entered into this Agreement in reliance upon the representations and warranties
given by them and that they are given with the intention of inducing the Investors to enter into this Agreement. 
 2.28 Warranties
Separate and Independent. Each of the warranties is separate and independent and, except as provided in the Schedule of Exceptions, is not limited: (a) by reference to any other paragraph of Section 2; or (b) by anything in
this Agreement, and none of the warranties shall be treated as qualified by any constructive knowledge on the part of the Investors or any of their respective agents. Each of the warranties is without prejudice to any other warranty and, except
where expressly stated otherwise, no provision contained in this Agreement shall govern or limit the extent or application of any other warranty. A reference made to a particular part of a document when making a disclosure under the Schedule of
Exceptions of any matter shall not be treated as a disclosure of the whole document. 
 2.29 Business Plan. The business plan of the
Group set forth in Exhibit E (the “Business Plan”), including the budget, capital expenditure plan and projections set forth therein, has been drawn up based on fair, proper and reasonable assumptions in good faith and
in a professional workmanlike manner and on a realistic basis, after due and careful consideration of all relevant facts and circumstances, and does not give a misleading indication of the prospects of the Group. There has been no omission from the
Business Plan that would make it misleading. 
  

 17 

 2.30 Transactions with Affiliates. Except as required by this Agreement, the Related Agreements,
the contractual arrangement between WFOE and OpCo or the transactions contemplated hereby or thereby, (i) no director or senior manager of any member of the Group, no spouse, parent, sibling or children of any such director or senior manager,
and no entity controlled by any of the foregoing, has any agreement, understanding, proposed transaction with, indebtedness owing to, commitments to make loans or to extend or guarantee credit from any member of the Group other than in the ordinary
course of business; (ii) the sum of the value of all agreements, understandings, proposed transactions with, indebtedness owing to, commitments to make loans or to extend or guarantee credit by all members of the Group with respect to any
director or senior manager of the Group, the spouse, parents, siblings and children of such director or senior manager, and any entity in which such director, senior manager or such relatives thereof have a direct or indirect ownership interest of
not less than 0.1%, do not exceed US$10,000; and (iii) no director or senior manager of any member of the Group, no spouse, parent, sibling or children of any such director or senior manager, and no entity controlled by any of the foregoing,
has any direct or indirect ownership interest in any affiliate of any member of the Group or in any firm or corporation that competes with any member of the Group. 
 2.31 Compliance with Laws; FCPA. Each member of the Group has complied with all applicable Law (including without limitation any Law in the jurisdiction of its organization and where it conducts business,
concerning bribery, corruption and anti-money laundering matters). Each Warrantor understands and is familiar with the U.S. Foreign Corrupt Practices Act of 1977, as amended (“FCPA”) and its purpose. None of the Warrantor has
taken any action or made any payment (including promises to take action or to make payments) in violation of, or that might cause any other party or its affiliates or subsidiaries to be in violation of FCPA. 
 2.32 Knowledge. In this Agreement, “Knowledge” means best knowledge, of the entity to which knowledge is attributed and
includes knowledge, information, belief or awareness that it would have if its principal executive and financial officers had made due and diligent enquiries and investigation. 
  

	3.	Representations and Warranties of the Investor. 

 Each Investor, severally and not jointly, hereby represents and warrants to the Company as follows: 
 3.1 Due Incorporation and
Valid Existence. Each Investor is duly organized, validly existing and in good standing (or equivalent status in the relevant jurisdiction) under, and by virtue of, the law of the place of its incorporation or establishment. 
 3.2 Authorization. This Agreement and the Related Agreements, when executed and delivered by such Investor, will each constitute a valid and
legally binding obligation of such Investor, enforceable in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, and any other laws of general application
affecting enforcement of creditors rights generally, and as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (ii) to the extent the indemnification provisions contained in
the Registration Rights Agreement may be limited by applicable securities laws. 
  

 18 

 3.3 Purchase Entirely for Own Account. This Agreement is made with the Investor in reliance upon
the Investor’s representation to the Company, which by the Investor’s execution of this Agreement the Investor hereby confirms, that the Series C Preferred Shares to be acquired by the Investor will be acquired for investment for the
Investor’s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof in violation of securities laws. The Investor represents that it has the requisite power and authority to enter into,
execute, deliver and perform this Agreement. 
 3.4 Investment Experience. Each Investor represents that such Investor is experienced
in evaluating and investing in private placement transactions of securities of companies in a similar stage of development to the Company and acknowledges that such Investor is able to fend for himself, herself or itself, can bear the economic risk
of such Investor’s investment, and has such knowledge and experience in financial and business matters that such Investor is capable of evaluating the merits and risks of the investment in the Securities. Without prejudice to the
representations and warranties of the Company herein or its obligations hereunder, the Investor has had the opportunity to inquire of the Company and its senior management regarding information the Investor believes is necessary for it to make an
informed decision in purchasing the Securities, has received all information so requested and has had the opportunity to conduct such due diligence review as it has deemed appropriate. 
 3.5 No Public Market. The Investor acknowledges that the Securities must be held indefinitely. The Investor understands that no public market now
exists for any of the securities issued by the Company, that the Company has made no assurances that a public market will ever exist for the Securities. 
 3.6 Compliance with Laws. Such Investor is satisfied as to the full observance of the securities laws of such Investor’s jurisdiction in connection with any invitation to subscribe for the Series C
Preferred Shares or any transaction contemplated by this Agreement, including (i) the legal requirements of such Investor’s jurisdiction for the purchase of the Series C Preferred Shares and (ii) any governmental or other consents
that may be relevant to the purchase, holding, redemption, sale or transfer of the Securities. Such Investor’s subscription and payment for, the Securities will not violate any applicable securities laws of such Investor’s jurisdiction.
Each Investor is an “accredited investor” as defined in Rule 501 of Regulation ‘D’ promulgated under the United States Securities Act of 1933, as amended. 
 3.7 Exemption from Registration. Each Investor understands that the offer and sale of the Series C Preferred Shares hereunder are intended to be
exempt from the registration or qualification requirements of all applicable securities laws and regulations, and that the reliance of the Company on such exemptions is predicated in part on such Investor’s representations set forth in this
Agreement. 
  

 19 

	4.	Conditions to Investors’ Obligations at Closing. 

 The obligations of each of the Investors at the Closing under this Agreement are subject to the fulfillment, or the waiver by each of the Investors, of the conditions set forth in this Section 4 on or
before the Closing: 
 4.1 Accuracy of Representations and Warranties. Each representation and warranty of the Warrantors contained in
this Agreement shall be true in all material respects (except that the representations and warranties contained in Section 2 that have already been qualified by materiality shall be true without additional qualification as to
materiality) on and as of the date of the Closing with the same effect as though such representation and warranty had been made on and as of that date without reference to the revised schedule contemplated by the immediately following sentence.
Immediately prior to the Closing, and with the Investors’ consent the Company may provide each of the Investors with a new Schedule of Exceptions, updated for the Closing, without prejudice to the condition to closing contained in the
immediately preceding sentence. 
 4.2 Performance. Each Warrantor shall have performed and complied in all respects with all
covenants, agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by it on or before the Closing. 
 4.3 Compliance Certificate. The chief executive officer of the Company shall deliver to the Investors at the Closing a certificate certifying that the conditions specified in Sections 4.1 and 4.2
have been fulfilled. 
 4.4 Qualifications and Consents. All of the Permits and the Consents that are required in connection with
the lawful consummation of the transactions provided for herein and in the Related Agreements (including, without limitation, the lawful issuance and sale of the Securities pursuant to this Agreement) shall be obtained and effective as of the
Closing without the imposition of any obligations, liabilities or conditions adverse to the Company or any Investor. Without limiting the generality of the foregoing, each of the Company’s existing shareholders shall have waived any preemptive
right or right of first offer (or any comparable right) any such shareholder may have to purchase any of the Securities and any past conversion price adjustment that resulted in a conversion ratio other than 1:1 in respect of any of the Series A
Preferred Shares and the Series B Preferred Shares. 
 4.5 Proceedings and Documents. All corporate and other proceedings in
connection with the transactions contemplated by this Agreement and the Related Agreements at the Closing and all documents incident thereto shall be reasonably satisfactory in form and substance to the Investors’ counsel, and the
Investors’ counsel shall have received all such counterpart original and certified or other copies of such documents as it may reasonably request. 
 4.6 Opinion of Company Counsel. The Investors shall have received from (i) Conyers, Dill & Pearman, special Cayman Islands counsel for the Company, a legal opinion dated as of the Closing, in the
form of Exhibit F; and (ii) Grandall Legal Group, special PRC counsel to the Group, a legal opinion dated as of the Closing, in the form of Exhibit G. 
 4.7 Board of Directors. The Restated Articles shall have been duly and validly adopted as at the Closing, shall be effective at law, and shall reflect that the Board of Directors of the Company shall consist of
five (5) members. As of the Closing, the Board of Directors of the Company shall include CHAN Yi Sing, WALECKA John Lawrence, GOH Yin Long, MEI Lijun and LEW Sampson Tony. 
  

 20 

 4.8 Registration Rights Agreement. The Company and each of the other Investors shall have executed
and delivered the Registration Rights Agreement. 
 4.9 Shareholders’ Agreement. Each holder of Ordinary Shares and Preferred
Shares listed on Exhibit D-1 and each of the other Investors shall have executed and delivered the Shareholders’ Agreement. 
 4.10 Officer’s Certificate. The Company’s Secretary shall have delivered to each Investor a certificate dated as of the Closing and signed by the Secretary certifying, among other things, true and correct copies of
(A) the Board of Directors and shareholder resolutions approving the transactions contemplated by this Agreement and the Related Agreements, (B) the Restated Articles, and (C) the updated registers of members and directors effective
as at the Closing. 
 4.11 No Material Adverse Change. Since the execution of this Agreement, there shall not have occurred any event
or condition which has a Material Adverse Effect on the business, assets, properties, liabilities or condition of any member of the Group. 
 4.12 No Litigation. There shall not be any action, suit, proceeding or investigation of or before any Governmental Authority pending or threatened (i) with respect to this Agreement, the Related Agreements or any of the
transactions contemplated hereby or thereby, or (ii) which could reasonably be expected to result in a Material Adverse Effect. 
 4.13
Share Certificates. At the Closing, the Company shall have tendered to each Investor a certificate representing Series C Preferred Shares purchased by such Investor hereunder. 
 4.14 Employment Agreement. Each of the Founders and the key employees identified on Schedule VI, shall have executed an Employment
Agreement in the form attached hereto as Exhibit H (the “Employment Agreement”). 
 4.15 Compensation
Committee. A compensation committee of the Company that, upon the Closing, shall be made up of CHAN Yi Sing, GOH Yin Long and LEW Sampson Tony shall have been established to formulate and determine on behalf of the Board of Directors, among
other things, the compensation, benefits and remuneration of directors, officers and employees of the Group, the terms of the Company’s share incentive plan and the grant of share options or other equity incentives by the Company. 

4.16 IP License Agreements. WFOE and OpCo shall have entered into Intellectual Property License Agreements in form attached hereto as
Exhibit I (“IP License Agreements”). 
 4.17 Due Diligence. A due diligence review of the Group
Companies (including but not limited to legal, financial, management, technology, Intellectual Property, process, licenses and government regulatory due diligence) shall have been completed to the satisfaction of the Investors. 
  

 21 

 4.18 Indemnification Agreement. An indemnification agreement in the form of Exhibit J shall
have been duly executed and delivered by the Company in favor of the nominee of the Investors to the Board of Directors. 
 4.19 Financial
Control Policies. The Group shall have adopted and implemented financial control and reporting policies and procedures satisfactory to the Investors. Without limiting the generality of the foregoing, prior to the Closing, the Company shall have
established the Main Account (as defined in Section 6.6 below) to the satisfaction of the Investors. 
 4.20 Conversion of
Notes. At the Closing, each of the holders of the Convertible Notes shall simultaneously with Closing have converted all of the principal and interest on the Convertible Notes held by such holder into Series C Preferred Shares at the conversion
price equal to US$0.20357356 per share, as set forth on Schedule VII and shall have released the Company from all of its obligations from the Convertible Notes held by such holder. 
 4.21 Exercise of Warrants. At the Closing, each of the holders of that certain warrants to purchase Series B Preferred Shares issued by the
Company on November 1, 2006 (the “Warrants”) shall simultaneously with Closing have exercised in full the Warrants held by such holder to purchase Series B Preferred Shares at the exercise price equal to US$0.113402 per
share as set forth on Schedule VIII. 
 4.22 CGEN Info. Shanghai CGEN Information System Co., Ltd. (

) (“CGEN Info”) shall have entered into Intellectual Property Transfer Agreements in form attached hereto as Exhibit K (“CGEN Info IP Agreements”) transferring
all of its ownership in any Intellectual Property (including without limitation trademarks of “OPT”, “CGEN” and “In-store Information Network”) used in the business or businesses of any member of the Group to WFOE for
nominal or no consideration (or in any event the lowest consideration permitted by the applicable Law of the PRC). 
 4.23 Tax Indemnity
Agreement. The Company and the Investors shall have entered into a Tax Indemnity Agreement in form attached hereto as Exhibit L. 
 If, as of December 31, 2006 the Company fails to tender to the Investors the documents specified herein which are required to be delivered to the Investors at the Closing or if at the Closing any of the conditions specified in this
Section 4 in respect of such Closing have not been fulfilled to each Investor’s satisfaction, or waived by each Investor, such Investor shall, at its election, be relieved of all further obligations under this Agreement, without
prejudice to any accrued rights it may have. 
  

	5.	Conditions of the Company’s Obligations at Closing. 

 The obligations of the Company under Section 1 of this Agreement are subject to the fulfillment, or waiver by the Company, of each of the following conditions on or before the Closing. 
 5.1 Representations and Warranties True at Closing. The representations and warranties of the Investors contained in Section 3 hereof
shall be true in all material respects on and as of the date of the Closing with the same effect as though said representations and warranties had been made on and as of that date. 
  

 22 

 5.2 Qualifications. All authorizations, approvals or permits, if any, of any Governmental
Authority that are required in connection with the lawful issuance and sale of the Securities pursuant to this Agreement shall be obtained and effective as of the date of the Closing; provided that Company shall have the benefit of reliance
upon this condition only if the Warrantors have made best efforts, to the satisfaction of the Investors, to obtain all such necessary authorizations, approvals or permits. 
 5.3 Covenants. All covenants, agreements and conditions contained in this Agreement to be performed by the Investors on or prior to Closing shall
have been performed or complied with. 
 5.4 Registration Rights Agreement. Each Investor shall have executed and delivered the
Registration Rights Agreement. 
 5.5 Shareholders’ Agreement. Each Investor shall have executed and delivered the
Shareholders’ Agreement. 
  

	6.	Affirmative Covenants of the Warrantors. 

 Each Warrantor hereby covenants and agrees with the Investors as follows: 
 6.1 Accounting and Reserves; Funding
Documentation. It shall maintain a standard and uniform system of accounting and shall keep proper books and records and accounts in which full, true and correct entries shall be made of its transactions, all in accordance with IFRS applied on a
consistent basis through all periods (including fiscal year 2006), and shall set aside on such books for each fiscal year all such proper reserves for depreciation, obsolescence, amortization, bad debts and other purposes in connection with its
operations as are required by such principles so applied. The funding of any member of the Group shall be effected in compliance with applicable Law of PRC and be properly documented and accounted for to the reasonable satisfaction of the Investors.

 6.2 Payment of Taxes and Claims. It shall pay and discharge promptly all Taxes imposed upon it or upon its income or profits or
upon any of its properties, real, personal or mixed, before the same shall become delinquent, as well as all lawful claims for labor, materials and supplies which, if unpaid, would by law become a lien or charge upon its properties; provided
that if both of the following conditions are met in any instance, it shall not be obligated, to pay or discharge, or to cause to be paid or discharged, such Taxes or claim: (i) if and for so long as it is contesting in good faith by appropriate
proceedings the amount, applicability or validity thereof, and (ii) if it has set aside on its books reserves deemed by it in accordance with IFRS to be adequate with respect to such tax, assessment, charge, levy or claim. 
 6.3 Availability of Ordinary Shares for Conversion. The Company shall at all times reserve and keep available out of its authorized but unissued
Ordinary Shares, such number of its duly authorized Ordinary Shares as shall be sufficient to effect the conversion of the Series C Preferred Shares. If at any time the number of authorized but unissued Ordinary Shares shall not 

  

 23 

 
be sufficient to effect the conversion of the Series C Preferred Shares, or otherwise comply with the terms of this Agreement or any Related Agreement, the
Company shall forthwith take such corporate action as may be necessary to increase its authorized but unissued Ordinary Shares to such number of shares as shall be sufficient for such purposes. 
 6.4 Governing Instruments. The Company shall not amend the Restated Articles in any manner adverse to the rights of the holders of the Series C
Preferred Shares. 
 6.5 Use of Proceeds. The Company shall use the entire proceeds (less reasonable expenses agreed by the Investors)
from the sale of the Series C Preferred Shares solely to purchase information technology and display panel equipment for installation in retail store networks or otherwise in accordance with the Business Plan, and in accordance with any control
procedures approved by the Investors in accordance with the Shareholders’ Agreement from time to time; except that the Company may repurchase from the Founders in the aggregate amount of US$1,500,000, comprising of 7,368,344 Ordinary Shares at
repurchase price no less than US$0.20357356 per share; provided that such repurchase shall be completed within 90 days of the date of the Closing and the Company shall give 10 days prior written notice of such repurchase to each Investor.

 Save as specifically provided in this Agreement, no Group Company shall use any proceeds for repayment of any debt or for the repurchase,
redemption or cancellation of any securities issued by any Group Company. 
 6.6 Bank Signatories. The proceeds from the sale of the
Series C Preferred Shares hereunder shall be deposited into a bank account of the Company in Hong Kong (the “Main Account”). The Main Account shall only be jointly operated, as at and after the Closing, only by the then chief
executive officer of the Company and a director of the Company appointed by the Investors (the “Main Account Signatories”). The amount of each transfer of funds out of the Main Account shall be at least US$250,000 (or if
transferring all the cash remaining in the Main Account, any lesser amount representing the balance of the Main Account at that time) and each such transfer shall require the joint signatures of the Main Account Signatories. 
 6.7 Intellectual Property; Change of Name. 
 (i) As soon as practicable (and in any case within 30 days from the date of the Closing), CGEN Info and WFOE shall record the CGEN Info IP Agreements and the transfer contemplated thereunder with the relevant PRC
Government Authorities. 
 (ii) As soon as practicable (and in any case within 30 days from the date of the Closing), WFOE and
OpCo shall record the IP License Agreements and the license contemplated thereunder with the relevant PRC Government Authorities. 
 (iii) As soon as practicable, each Warrantor shall take all necessary or desirable actions (including without limitation, executing additional documents) to effect the transfer any Intellectual Property used in the business or businesses of
any member of the Group from CGEN Info and/or OpCo to WFOE for nominal or no consideration. 
  

 24 

 (iv) As soon as practicable (and in any case within 30 days from the date of the
Closing), CGEN Info shall apply to the relevant PRC Government Authorities to change its name so that the phrase “CGEN” and/or “(GRAPHIC)” will not appear in its name or the translation thereof. 
 6.8 FY 2007 Financial Statements. The Company shall, as soon as practicable but in any event no later than April 30, 2008 deliver to each
Investor the FY 2007 Financial Statements (together with all attachment thereto). 
  

	7.	Miscellaneous Provisions. 

 7.1
Indemnity. The Company agrees to indemnify and hold harmless each Investor, and such Investor’s directors, officers, employees, affiliates, agents and assigns (each, an “Indemnitee”), against any and all
Indemnifiable Losses to such Indemnitee, directly or indirectly, as a result of, or based upon or arising from any inaccuracy in or breach of nonperformance of any of the representations, warranties, covenants or agreements made by any Warrantor in
or pursuant to this Agreement. For purposes of this Section, “Indemnifiable Loss” means, with respect to any Indemnitee, any action, cost, damage, disbursement, expense, liability, loss, deficiency, diminution in value,
obligation, penalty or settlement of any kind or nature, whether foreseeable or unforeseeable, including, but not limited to, (i) interest or other carrying costs, penalties, legal, accounting and other professional fees and expenses reasonably
incurred in the investigation, collection, prosecution and defense of claims and amounts paid in settlement, that may be imposed on or otherwise incurred or suffered by such Indemnitee and (ii) any taxes that may be payable by such Indemnitee
as a result of the indemnification of any Indemnifiable Loss hereunder. 
 7.2 Inconsistent Agreements. The Company shall not, and it
shall cause each of its subsidiaries not to, enter into any agreement containing any provision that would (a) be violated or breached by the exercise or performance by the Company or its subsidiary of any of their respective rights or
obligations under this Agreement or any Related Agreement or (b) impair in any material respect the ability of the Company or any subsidiary to comply with the terms of this Agreement or any Related Agreement. 
 7.3 Survival. The warranties, representations and covenants of the Company and the Investors contained in or made pursuant to this Agreement shall
in no way be limited, diminished or affected by any investigation made by or on behalf of the Investors and shall survive the execution and delivery of this Agreement for a period of 36 months thereafter except that Sections 2.20 and
6.2 shall survive until 6 months after the expiration of the applicable statute of limitation. 
 7.4 Transfer of Successors and
Assigns. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties hereto. This Agreement may not be assigned by any party hereto without the prior written
consent of the other parties to this Agreement; provided, however, that this Agreement may be assigned to any affiliate of an Investor or any subsequent holder of any Securities. Nothing in this Agreement, express or
implied, is intended to confer upon any party other than the parties hereto or their respective permitted successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in
this Agreement. 
  

 25 

 7.5 Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws
of the State of New York, excluding those laws that direct the application of the laws of another jurisdiction. 
 7.6 Dispute
Resolution. 
 (a) Any dispute, controversy or claim (each, a “Dispute”) arising out of or relating to this
Agreement shall be resolved first through consultation. Such consultation shall begin immediately after one party hereto has delivered to the other party hereto a written request for such consultation. If within 30 days following the date on which
such notice is given, the Dispute cannot be resolved through consultation, such Dispute shall be submitted to arbitration upon the request of any party to the Dispute with notice to each other party to the Dispute (the “Arbitration
Notice”). 
 (b) The arbitration shall be conducted in Hong Kong under the auspices of the Hong Kong International Arbitration
Center (“Center”). There shall be three (3) arbitrators. Each party to the Dispute shall choose one arbitrator. The Secretary General of the Center shall select the third arbitrator, who shall be qualified to practice
law in Hong Kong. If any of the members of the arbitral tribunal have not been appointed within thirty (30) days after the Arbitration Notice is given, the relevant appointment shall be made by the Secretary General of the Center. 

(c) The arbitration proceedings shall be conducted in English. The arbitration tribunal shall apply the Arbitration Rules of the United Nations
Commission on International Trade Law, as in effect at the time of the arbitration. However, if such rules are in conflict with the provisions of this Section 7.6, including the provisions concerning the appointment of arbitrator, the
provisions of this Section 7.6 shall prevail. 
 (d) Each party to the arbitration shall cooperate with each other party to the
arbitration in making full disclosure of and providing complete access to all information and documents requested by such other party in connection with such arbitration proceedings, subject only to any confidentiality obligations binding on such
party. 
 (e) The award of the arbitration tribunal shall be final and binding upon the parties, and the prevailing party may apply to a
court of competent jurisdiction for enforcement of such award. 
 (f) The arbitrator shall decide any Dispute submitted by the parties to the
arbitration strictly in accordance with the substantive law of the State of New York and shall not apply any other substantive law. 
 (g)
Any party to the Dispute shall be entitled to seek preliminary injunctive relief, if possible, from any court of competent jurisdiction pending the constitution of the arbitral tribunal. 
  

 26 

 (h) During the course of the arbitration tribunal’s adjudication of the Dispute, this Agreement
shall continue to be performed except with respect to the part in dispute and under adjudication. 
 7.7 Counterparts. This Agreement
may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 7.8 Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement. 
 7.9 Notices. 
 (a) All notices,
requests, demands and other communications under this Agreement or in connection herewith shall be given to or made upon (i) the Investors at each such Investors address set forth on Schedule XI with a copy to counsel to such Investor
indicated thereon; and (ii) any Warrantor at c/o CGEN Digital Media Company Limited, Suite 3293-94, Tower B, City Center of Shanghai, No. 100 Zunyi Rd., Shanghai 200051; fax: +86 21 6237 1918, attention: Chief Executive Officer, with a
copy to Paul Hastings Janofsky & Walker, 22/F Bank of China Tower, 1 Garden Road, Hong Kong; fax: +852 2526 2119, attention: Basil Hwang. 
 (b) All notices, requests, demands and other communications given or made in accordance with the provisions of this Agreement shall be in writing, and shall be sent by airmail, return receipt requested, or by facsimile with confirmation of
receipt, and shall be deemed to be given or made when receipt is so confirmed. 
 (c) Any party may, by written notice to the Company, alter
its address or respondent, and such notice shall be considered to have been given three (3) days after the airmailing or faxing thereof. 
 7.10 Expenses. Each of the Company and the Investors shall bear their own expenses incurred with respect to this Agreement, the Related Agreements and the transactions contemplated hereby and thereby; provided,
however, that the Company will pay at the Closing the reasonable out-of-pocket expenses of the Investors, including, without limitation, the reasonable fees and expenses of one firm of counsel to the Investors, attributable to the
legal due diligence, negotiation, execution and delivery of this Agreement, the Related Agreements or the transactions contemplated hereby, transaction fees, fees and expenses in connection with financial due diligence and travel expenses in an
amount not exceeding US$500,000. 
 7.11 Attorneys’ Fees. If any action at law or in equity (including arbitration) is necessary
to enforce or interpret the terms of this Agreement or any Related Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such party may be
entitled as determined by such court, equity or arbitration proceeding. 
  

 27 

 7.12 Amendments and Waivers. Any term of this Agreement may be amended only with the written
consent of the Company and the Investors. Any amendment or waiver effected in accordance with this Section 7.12 shall be binding upon each of the Investors and each transferee of the Securities, each future holder of all such securities
and the Company. 
 7.13 Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law,
portions of such provisions, or such provisions in their entirety, to the extent necessary, shall be severed from this Agreement and the balance of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in
accordance with its terms. 
 7.14 Delays or Omissions. No delay or omission to exercise any right, power or remedy accruing to any
holder of any of the Securities, upon any breach or default of the Company under this Agreement shall impair any such right, power or remedy of such holder nor shall it be construed to be a waiver of any such breach or default, or an acquiescence
therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or
approval of any kind or character on the part of any holder of any breach or default under this Agreement, or any waiver on the part of any holder of any provisions or conditions of this agreement, must be in writing and shall be effective only to
the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any holder shall be cumulative and not alternative. 
 7.15 Entire Agreement. This Agreement and the documents referred to herein constitute the entire agreement between the parties hereto pertaining
to the subject matter hereof, and any and all other written or oral agreements existing between the parties hereto are expressly canceled. 
 7.16 Further Assurances. Upon request of any of the Investors, all parties hereto agree to promptly execute and deliver all such other instruments and take all such other actions as any Investor may reasonably request from time to
time in order to effectuate and carry out the purposes, privileges, restrictions, rights and duties of the parties and the other provisions of this Agreement and the Related Agreements. 
 7.17 Specific Performance. The parties hereby declare that it is impossible to measure in money the damages that will accrue to a party hereto by
reason of a failure to perform any of the obligations under this Agreement and that a breach hereof shall cause irreparable injury and, in addition to any other right or remedy available to the parties hereto at law or in equity, any injured party
hereunder shall be entitled to enforcement by court injunction or specific performance of the obligations of the parties hereunder, without the necessity for posting a bond. Notwithstanding the foregoing sentence, nothing herein shall be construed
as prohibiting any injured party hereunder from also pursuing any other rights or remedies for such breach or threatened breach, including receiving damages and attorneys’ fees. The election of any remedy shall not be construed as a waiver on
the part of any injured party hereunder of any right such party may otherwise have at law or in equity, which rights and remedies shall be cumulative. 
 7.18 Understanding Among Investors. The decision of each Investor to purchase Securities pursuant to this Agreement has been made by such Investor independently of any other Investor and independently of any
statements or opinions as to the condition (financial or 

  

 28 

 
otherwise) of the Company that may have been made or given by any other Investor or by any agent or employee of any other Investor. Each Investor
acknowledges that no other Investor has acted as agent for such Investor in connection with making its investment hereunder and that no other Investor will be acting as agent of such Investor in connection with monitoring its investment hereunder.

 7.19 Publicity. Except as may be required by applicable law, the Company shall not use the name of, or make reference to, any
Investor or any of its affiliates in any press release or in any public manner without such Investor’s prior written consent. 
 7.20
Confidentiality and Non-Disclosure. 
 (a) Each Investor acknowledges that the Company could be irreparably damaged if trade secrets
concerning the business and affairs of the Company were disclosed to or utilized on behalf of any person. Each of the Investors covenants and agrees to and with the Company that, except as otherwise provided in this Agreement, it will not, at any
time, directly or indirectly, without the prior written consent of the Company, divulge, and will not authorize any of its partners, shareholders, directors, officers, employees or agents to divulge, to any person any trade secrets if such release
is intended for, or may result in, its public dissemination. The foregoing requirements of confidentiality shall not apply to information: (i) that is now or in the future becomes freely available to the public through no fault of or action by
such Investor; (ii) that is in the possession of such Investor or the using or disclosing party prior to the time such information was obtained from the Company or that is independently acquired by such Investor or the using or disclosing party
without the aid, application or use of such other information; (iii) that is obtained by such Investor or the using or disclosing party in good faith without knowledge of any breach of a secrecy arrangement from a third party; or (iv) that
is required to be disclosed by applicable Law or order of Government Authority or self-regulatory body (including, without limitation, the Hong Kong Stock Exchange). 
 (b) Non-Disclosure of Terms. The terms and conditions of this Agreement, the Related Agreements and all exhibits and schedules attached hereto and thereto (collectively, the “Financing
Terms”), including their existence, shall be considered confidential information and shall not be disclosed by any party hereto to any third party except in accordance with the provisions set forth below; provided that such
confidential information shall not include any information that is in the public domain other than by the breach of the confidentiality obligations hereunder. 
 (c) Press Releases, Etc. Any press release issued by any party hereto or any member of the Group shall not disclose any of the Financing Terms and the final form of such press release shall be approved in
advance in writing by the Investors. No other announcement regarding any of the Financing Terms in a press release, conference, advertisement, announcement, professional or trade publication, mass marketing materials or otherwise to the general
public may be made without each Investor’s prior written consent at its sole discretion. 
 (d) Permitted Disclosures.
Notwithstanding anything in the foregoing to the contrary: 
 (i) any party hereto may disclose any of the Financing Terms to its current or
bona fide prospective investors, directors, officers, employees, shareholders, investment 

  

 29 

 
bankers, lenders, accountants, auditors, insurers, business or financial advisors, and attorneys, in each case only where such persons or entities are under
appropriate nondisclosure obligations imposed by professional ethics, Law or otherwise; 
 (ii) each Investor (and its fund manager) may,
without disclosing the identities of the other Investors or the Financing Terms of their respective investments in the Company without their or the Company’s consent, disclose such Investor’s investment in the Company to third parties or
to the public at its sole discretion and in relation thereto may use the Company’s logo and trademark (without requiring the Company’s further consent). If it does so, the other parties shall have the right to disclose to third parties any
such information disclosed in a press release or other public announcement by such Investor. 
 (iii) notwithstanding clause
(d) (i) immediately above, each Investor shall have the right to disclose: 
 (A) any information to such Investor’s and/or its
fund manager’s and/or its Affiliate’s legal counsel, fund manager auditor, insurer, accountant, consultant or to an officer, director, general partner, limited partner, its fund manager, shareholder, investor, bona fide potential investor,
counsel or advisor, or employee of such Investor and/or its Affiliate; provided, however, that any such person shall be advised of the confidential nature of the information or are under appropriate non-disclosure obligation imposed by
professional ethics, Law or otherwise; 
 (B) any information for fund and inter-fund reporting purposes; 
 (C) any information as required by Law, Government Authorities, exchanges and/or regulatory bodies; and/or 
 (D) any information to bona fide prospective purchasers/investors of any share, security or other interests in the Company, 
 (E) any information contained in press releases or public announcements of the Company pursuant to Section 7.20(c) above. 
 (iv) the confidentiality obligations set forth in this Section 7.20 do not apply to: 
 (A) information which was in the public domain or known to the relevant party before it was furnished to it by another party hereto otherwise than as a
result of (i) a breach by that party of this Section 7.20 or (ii) a breach of a confidentiality obligation by a third party discloser, where the breach was actually known to that relevant party; 
 (B) information the disclosure of which is necessary in order to comply with any applicable Law, the order of any court, the requirements of a stock
exchange or to obtain tax or other clearances or consents from any relevant authority; or 
  

 30 

 (C) information disclosed by any director or observer of the Company to its appointer or any of its
Affiliates or to any person to whom disclosure would be permitted in accordance with the foregoing provisions of this Section 7.20(d). 
 (e) Legally Compelled Disclosure. In the event that any party is requested or becomes legally compelled (including without limitation, pursuant to securities laws and regulations) to disclose the existence of this Agreement and
exhibits and schedules attached to such agreement, or any of the Financing Terms hereof in contravention of the provisions of this Section 7.20, such party (the “Disclosing Party”) shall provide the other parties
(the “Non-Disclosing Parties”) with prompt written notice of that fact and use all reasonable efforts to assist an affected Non-Disclosing Party to seek a protective order, confidential treatment or other appropriate remedy.
In such event, the Disclosing Party shall furnish only that portion of the information that is legally required and shall exercise reasonable efforts to keep confidential such information to the extent reasonably requested by any Non-Disclosing
Party. 
 (f) Notices. All notices required under this Section 7.20 shall be made pursuant to Section 7.9 of
this Agreement. 
 (g) This Section 7.20 constitutes the entire agreement between the parties as to the matter of confidentiality
and supersedes any separate nondisclosure agreements executed by the Company with the Investors (and/or their Affiliates) with respect to the transactions contemplated herein. This Section 7.20 shall survive the termination of this
Agreement and the other Related Documents. 
 7.21 Investors’ Rights. Any rights of any Investor under this Agreement may,
without prejudice to such Investor to exercise any such rights, be exercised by any fund manager of such Investor or their respective nominees (the “Fund Manager”), unless such Investor has given notice to the other parties
to this Agreement that any such rights cannot be exercised by such Fund Manager. 
  

	8.	Definitions. 

 8.1 Defined Terms

 As used here in shall, the following terms shall have the following respective meanings: 
 “Affiliate” means, with respect to any Person, any of (a) a director, officer or partner of such Person, (b) a spouse,
parent, sibling or descendant of such Person or a spouse, parent, sibling or descendant of a director, officer, or partner of such Person and (c) any other Person that, directly or indirectly, through one or more intermediaries, controls, or is
controlled by, or is under common control with, another Person; and in the case of an Investor, shall include (i) any Person who holds Shares as a nominee for such Investor, (ii) any shareholder of such Investor, (iii) any entity or
individual which has a direct and indirect interest in such Investor (including, if applicable, any general partner or limited partner) or any fund manager thereof; (iv) any Person that directly or indirectly controls, is controlled by, under
common control with, or is managed by such Investor or its fund manager, (v) the relatives of any individual referred to in (iii) above, and (vi) any trust controlled by or held for the benefit of such individuals. For the avoidance
of 

  

 31 

 
doubt, no Investor shall be deemed to be an Affiliate of any Member of Company Group or of OpCo. The term “control” includes, without
limitation, the possession, directly or indirectly, of the power to direct the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise. Without limiting the generality of the above, the term
“Affiliate” in the case of CPI Ballpark Investments Ltd. shall include any Affiliate of Merrill Lynch (Asia Pacific) Limited. 
 “Agreement” has the meaning ascribed to it in the Preamble of this Agreement. 
 “Arbitration Notice” has the meaning ascribed to it in Section 7.6(a). 
 “Audited Balance
Sheet Date” has the meaning ascribed to it in Section 2.17(a). 
 “Business Plan” means the
business plan of the Group set forth in Exhibit E. 
 “Center” has the meaning ascribed to it in
Section 7.6(b). 
 “CFC” has the meaning ascribed to it in Section 2.20(c). 
 “CGEN HK” has the meaning ascribed to it in the Preamble of this Agreement. 
 “CGEN Info” has the meaning ascribed to it in Section 4.22. 
 “CGEN Info IP Agreements” has the meaning ascribed to it in Section 4.22. 
 “Closing” means the closing of the transaction contemplated by Section 1.3. 
 “Code” has the meaning ascribed to it in Section 2.20(c). 
 “Company” has the meaning ascribed to it in the Preamble of this Agreement. 
 “Consent” has the meaning ascribed to it in Section 2.6. 
 “Contract” means any agreement, contract, lease, bond debenture, commitment, note, other evidence of indebtedness, letter of
credit, license, evidence of indebtedness, mortgage, understanding or indenture whether in writing or not. 
 “Disclosing
Party” has the meaning ascribed to it in Section 7.20(e). 
 “Dispute” has the meaning
ascribed to it in Section 7.6(a). 
 “Employment Agreement” has the meaning ascribed to it in
Section 4.14. 
 “Encumbrances” means any mortgage, pledge, assessment, security interest, lease, lien,
levy charge or other encumbrance of any kind, or any provision in any conditional sale Contract, title retention Contract or other Contract that gives rise to any of the foregoing. 
  

 32 

 “ESOP Plan” means the plan adopted by the Company granting or reserving up to
23,296,518 Ordinary Shares for issuance under options to purchase Ordinary Shares to present or former employees, officers or consultants of the Company. 
 “FCPA” has the meaning ascribed to it in Section 2.31. 
 “Financial Statements” has the meaning ascribed to it in Section 2.17(a). 
 “Financing Terms” has the meaning ascribed to it in Section 7.20(b). 
 “Founder” or “Founders” has the meaning ascribed to it in the Preamble of this Agreement. 
 “Fund Manager” has the meaning ascribed to it in Section 7.21. 
 “FY 2007 Financial
Statements” has the meaning ascribed to it in the Restated Articles. 
 “Governmental Authority”
means any government or any agency, bureau, board, commission, court, department, official, political subdivision, tribunal or other instrumentality of any government. 
 “Group”, “Group Company”, “member of the Group” or “Group member” has the meaning ascribed to them in
Section 2.1. 
 “Group’s Intellectual Property” has the meaning ascribed to it in
Section 2.9(a)(i). 
 “IFRS” has the meaning ascribed to it in Section 2.17(h). 

“Indemnifiable Loss” has the meaning ascribed to it in Section 7.1. 
 “Indemnitee” has the meaning ascribed to it in Section 7.1. 
 “Intellectual Property” the meaning ascribed to it in Section 2.9(a). 
 “Investor” or “Investors” has the meaning ascribed to it in the Preamble of this Agreement. 

“IP License Agreements” has the meaning ascribed to it in Section 4.16. 
 “Knowledge” has the meaning ascribed to it in Section 2.32. 
 “Law” means any and all provisions of any constitution, treaty, statute, law, regulation, ordinance, code, rule, judgment, rule
of common law, order, decree, award, injunction, governmental approval, concession, grant, franchise, license, Contract, directive, requirement, or other governmental restriction or any similar form of decision of, or determination by, or any
interpretation or administration of any of the foregoing by, any Government Authority. 
 “Licensed IP” has the
meaning ascribed to it in Section 2.9(a)(ii). 
  

 33 

 “Main Account” has the meaning ascribed to it in Section 6.6.

 “Main Account Signatories” has the meaning ascribed to it in Section 6.6 
 “Management Accounts” has the meaning ascribed to it in Section 2.17(b). 
 “Material Adverse Effect” has the meaning ascribed to it in Section 2.1. 
 “Non-Disclosing Parties” has the meaning ascribed to it in Section 7.20(e). 
 “OpCo” has the meaning ascribed to it in the Preamble of this Agreement. 
 “OpCo Call Option” has the meaning ascribed to it in Section 2.4(c)(iii). 
 “Ordinary Shares” has the meaning ascribed to it in Recitals of this Agreement. 
 “Permit” has the meaning ascribed to it in Section 2.7. 
 “Person” means any natural person, corporation, limited liability company, general partnership, limited partnership,
proprietorship, other business organization, trust, union, association or Governmental Authority. 
 “PFIC” has the
meaning ascribed to it in Section 2.20(c). 
 “PRC” means the People’s Republic of China and, for
the purpose of this Agreement, excluding Hong Kong Special Administrative Region, Macau Special Administrative Region and the Islands of Taiwan. 
 “Preferred Shares” has the meaning ascribed to it in Section 2.3(a). 
 “Registration
Rights Agreement” has the meaning ascribed to it in Section 2.2. 
 “Related Agreements” has
the meaning ascribed to it in Section 2.2. 
 “Restated Articles” has the meaning ascribed to it in
Section 1.1. 
 “Scheduled Contracts” has the meaning ascribed to it in Section 2.11(c).

 “Scheduled of Exceptions” has the meaning ascribed to it in Section 2. 
 “Securities” has the meaning ascribed to it in the Recitals of this Agreement. 
 “Series A Preferred Shares” has the meaning ascribed to it in Section 2.3(a). 
 “Series B Preferred Shares” has the meaning ascribed to it in Section 2.3(a). 
 “Series C Preferred Shares” has the meaning ascribed to it in the Recitals of this Agreement. 
  

 34 

 “Shareholders’ Agreement” the meaning ascribed to it in
Section 2.2. 
 “Subsidiaries” means any or all of the Company’s direct and indirect subsidiaries.

 “Tax Return” means any central, provincial or local tax return, report, statement and other similar filings
required to be filed by any member of the Group with respect to Taxes. 
 “Taxes” or
“Taxation” means and includes all forms of tax, levy, duty, charge, impost, fee, deduction or withholding of any nature imposed, levied, collected, withheld or assessed by any Governmental Authority or other taxing or similar
authority in any part of the world and includes (i) any interest, additional tax, penalty or other charge payable or claimed in respect thereof and (ii) any central, provincial or local taxes, assessments, interest, penalties,
deficiencies, fees and other governmental charges or impositions. 
 “Unaudited Management Account Date” has the
meaning ascribed to it in Section 2.17(b). 
 “Warrantor” or “Warrantors” has the
meaning ascribed to it in the Preamble of this Agreement. 
 “Warrants” has the meaning ascribed to it in Section
4.21. 
 “WFOE” has the meaning ascribed to it in the Preamble of this Agreement. 
 8.2 Construction of Certain Terms and Phrases. Unless the context of this Agreement otherwise requires, (i) words of any gender include each
other gender; (ii) words using the singular or plural number also include the plural or singular number, respectively; (iii) the terms “hereof,” “herein,” “hereby,” “hereunder” and derivative or
similar words refer to this entire Agreement; (iv) the terms “Section” refer to the specified Section of this Agreement; and (v) the phrase “ordinary course of business” refers to the business of the Company consistent
with past custom and practice. Whenever this Agreement refers to a number of days, such number shall refer to calendar days. Any representation or warranty contained herein as to the enforceability of a Contract (including this Agreement) shall be
subject to the effect of any bankruptcy, insolvency, reorganization, moratorium or other similar law affecting the enforcement of creditors’ rights generally and to general equitable principles (regardless of whether such enforceability is
considered in a proceeding in equity or at law). 
 [Signature Pages to Follow] 
  

 35 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first written above.

  

					
		 		 	COMPANY:
	 Address:
 Suite 3293-94, Tower
B,
 City Center of Shanghai
 No. 100 Zunyi Rd.
 Shanghai 200051, P.R. China
  
 Fax: +86 21 6237 1918
 Attention: CEO
	 		 	CGEN DIGITAL MEDIA COMPANY LIMITED
	 		 	
	 		 	
	 		 	
	 		 	
	 		 	/s/
		 		 	By:
		 		 	Title:

  

					
		 		 	CGEN HK:
			
		 		 	CGEN DIGITAL MEDIA COMPANY LIMITED
			
	 	 		 	/s/
		 		 	By:
		 		 	Title:
			
		 		 	WFOE:
			
		 		 	 CGEN DIGITAL TECHNOLOGY
 (SHANGHAI) CO.,
LTD.

		 		 	[GRAPHIC]
			
	 	 		 	/s/
		 		 	By:
		 		 	Title:
			
		 		 	OPCO:
			
		 		 	 SHANGHAI CGEN DIGITAL MEDIA
 NETWORK CO.,
LTD.

		 		 	[GRAPHIC]
			
	 	 		 	/s/
		 		 	By:
		 		 	Title:

 [SIGNATURE PAGE TO PURCHASE AGREEMENT] 

					
			
		 		 	FOUNDERS:
			
	 	 		 	/s/
		 		 	Chan Yi Sing
		 		 	(Singapore NRIC No. S1306068A)
			
	 	 		 	/s/
		 		 	Tian Guanyong    

		 		 	(PRC ID No. 133031651224065)
			
	 	 		 	/s/
		 		 	Cao Xiaofeng    

		 		 	 (PRC ID No. 310112197008270052)

			
	 	 		 	/s/
		 		 	Yao Fang    

		 		 	(PRC ID No. 310221670521081)
			
	 	 		 	/s/
		 		 	Zhu Hai Guang    

		 		 	(PRC ID No. 410423197106070010)

 [SIGNATURE PAGE TO PURCHASE AGREEMENT] 

					
		 		 	INVESTORS:
			
	 Address:
 c/o Merrill Lynch (Asia Pacific)
Limited,
 17/F ICBC Tower, 3 Garden Road, Central,
 Hong Kong

 Tel: 852 2161 7650
 Fax: 852 2161 7148
 Attention: Sampson Lew, Vice President
	 		 	CPI BALLPARK INVESTMENTS LTD.
	 		 	
	 		 	
	 		 	
	 		 	
	 		 	/s/
	 		 	By:
	 		 	Title:
			
		 		 	  

 [SIGNATURE PAGE TO PURCHASE AGREEMENT] 

					
		 		 	INVESTORS:
			
	 Address:
 Unit 2505, K. WAH
Center
 1010 Huaihai Zhong Road
 Shanghai 200031
 People’s Republic of China
  
 Fax:                +86 (21) 5404-7557
 Attention: Ian Goh
	 		 	TDF CAPITAL CHINA II, LP
	 		 	
	 		 	
	 		 	
	 		 	
	 		 	/s/
	 		 	By:
	 		 	Title:
			
		 		 	TDF CAPITAL ADVISORS, LP
			
		 		 	/s/
		 		 	By:
		 		 	Title:
			
		 		 	  
			
		 		 	  

 [SIGNATURE PAGE TO PURCHASE AGREEMENT] 

					
		 		 	INVESTORS:
			
	 Address:
  
 3000 Sand Hill Road
 Building 2, Suite 290
 Menlo Park, CA 94025
  
 Fax: 650-854-5762
 Attention: John L. Walecka
	 		 	REDPOINT VENTURES II, L.P.
	 		 	By its General Partner Redpoint Ventures II, LLC
	 		 	
	 		 	
	 		 	
	 		 	/s/
	 		 	By:
	 		 	Title:
			
		 		 	  
		 		 	REDPOINT ASSOCIATES II, LLC
			
		 		 	/s/
		 		 	By:
		 		 	Title:
			
		 		 	  

 [SIGNATURE PAGE TO PURCHASE AGREEMENT] 

 Schedule I 
 Investors 
  

									
	 Investor
	  	Number of Series C
Preferred Shares
Subscribed at Closing	  	Purchase Price
Per Series C
Preferred Share	  	Purchase Price
	 CPI BALLPARK INVESTMENTS LTD.
	  	73,683,439	  	US$	0.20357356	  	US$	14,999,999.99
	 REDPOINT VENTURES II, L.P.
	  	12,068,608	  	US$	0.20357356	  	US$	2,456,849.50
	 REDPOINT ASSOCIATES II, LLC
	  	279,057	  	US$	0.20357356	  	US$	56,808.63
	 TDF CAPITAL CHINA II, LP
	  	11,589,072	  	US$	0.20357356	  	US$	2,359,228.64
	 TDF CAPITAL ADVISORS, LP
	  	497,988	  	US$	0.20357356	  	US$	101,377.19
		  	 	  			  	 	 
	 TOTAL
	  	98,118,164	  			  	US$	19,974,263.95
		  	 	  			  	 	 

 Schedule II 
 Schedule of Exceptions 
 This Schedule of Exceptions is made and given pursuant to Section 2 of the
Series C Preferred Shares Purchase Agreement dated as of December 5, 2006 (the “Agreement”), by and among the Company, CGEN HK, WFOE, OpCo, the Founders and each of the other parties, severally and not jointly, whose names are
set forth on the Schedule of Investors attached to the Agreement as Schedule I. Unless the context otherwise requires, all capitalized terms are used herein as defined in the Agreement. The item numbers below correspond to the item numbers of
the Company’s Representations in the Agreement. Disclosure made under one heading apply to and/or qualify only the correspondingly numbered representation of the Company in Section 2 of the Agreement except to the extent that it is
reasonably apparent from the text of the disclosure itself that such disclosure also applies to another representation. Each disclosure made herein shall be deemed to be a joint and several representation and warranty of the Warrantors as to the
information or matters disclosed to the like extent as if set forth in full in Section 2 of the Agreement. 
 Section 2.8 Litigation

 OpCo has a lawsuit pending against Shanghai Focus Media Advertising Company Limited and Focus Media Holding Limited. OpCo has provided relevant
documents to the Investors’ counsel during the due diligence. 
 Section 2.9 Patents and Other Intangible Assets 
 (b) Intellectual Property Material to the Business of Any Member of the Group: 
  

	 	1.	Media Two software owned by WFOE; 

  

	 	2.	“OPT” trade mark co-owned by Shanghai CGEN Information System Co., Ltd. (

) (“CGEN Info.”) and OpCo; 

  

	 	3.	“In-store Information Network” (

) trade mark co-owned by CGEN Info. and OpCo; 

  

	 	4.	“CGEN” trade mark owned by CGEN Info. 

 The Company is in the
process of transferring the ownership over the intellectual property #2 through #4 to WFOE. 
 (d) There will be an indemnification agreement with the
director appointed by the Investors. 

 Section 2.11 Agreements, Action 
 (a) Please see the attached contract chart. 
 (b) Please see the attached contract chart. 
 (c) Please see the attached contract chart. 
 (d) The Company has
repurchased 16,493,544 preferred shares of JDC prior to Series B financing pursuant to the JCDecaux Letter Agreement dated as of 16th of January, 2006. 
 Section 2.12 Brokers or Finders 
 The Company has entered into a Financial
Advisor Contract dated as of 6th of June, 2006 with Dragonrise in connection with this Agreement and the Related Agreements. 
 Section 2.13 No Conflict of Interest 
 The equity interests in
OpCo are owned by the spouse of the Chairman of the Company and three other individuals employed by Group Companies. OpCo licenses software and intellectual property from WFOE. 
 Section 2.15 Corporate Documents and Minute Books 
 CGEN HK is in the process of arranging for the filing of the
relevant documents with the Companies Registry of Hong Kong in respect of the resignation of Yao Fang as director, the appointments of Goh Yin Long and Zhu Jian Huan as directors and Tina Lin Chi Ju and Vincent Chan Chun Hung as alternate directors.

 Section 2.18 Changes 
 (g) WFOE is entering into
a trade mark transfer agreement with CGEN Info and will register with government authority upon the execution as required by law. 
 (m) The Company has
repurchased 16,493,544 preferred shares of JDC prior to Series B financing pursuant to the JCDecaux Letter Agreement dated as of 16th of January, 2006; 
 On
November 1, 2006, the Company issued certain warrants to and entitling some of its existing shareholders to purchase 3,527,278 Series B Preferred Shares at a total purchase price of US$400,000. 
 (o) The Company issued convertible notes for a US$4,000,000 bridge loan from some of its existing shareholders on November 1, 2006. 

 Section 2.19 Employment Benefits Plans 
 The Company has Employee Stock Option Plan and Sales Incentive Plan in effect. 
 The Company has entered into employment
contracts and non-compete agreements with Chan Yi Sing and Tian Guan Yong. WFOE and the OpCo have entered into employment contracts and non-compete agreements with each of their employees. Both WFOE and OpCo are obligated to make severance payment
to the employees for early termination as required by the PRC Employment Law. 
 Section 2.25 Other Representations and Warranties Relating to WFOE
and OpCo. 
  

	(a)	WFOE is entering into a trade mark transfer agreement with CGEN Info and will register with government authority upon the execution as required by law. 

  

	(b) & (c)	The beneficial shareholders of WFOE have not yet registered with State Administration of Foreign Exchange (“SAFE”) as required by SAFE No. 75 Circular.

  

	(d)	Pursuant to the OpCo Call Option Agreement, WFOE has the call option to purchase all the equity interest in the OpCo under certain conditions specified therein

 Schedule III 
 Particulars of the Company 
  

					
	Name	 	:	  	CGEN DIGITAL MEDIA COMPANY LIMITED
			
	Place of Incorporation	 	:	  	Cayman Islands
			
	Registration No.	 	:	  	CR-145540
			
	Date of Incorporation	 	:	  	24 February 2005
			
	Registered Address	 	:	  	4th Floor, P.O. Box 2804, George Town, Grand Cayman, Cayman Islands
			
	Authorised Share Capital	 	:	  	700,000,000 ordinary shares, par value US$0.000001 per share;
			
		 		  	100,000,000 Series A Preferred Shares, par value US$0.000001 per share; and
			
		 		  	130,000,000 Series B Preferred Shares, par value US$0.000001 per share.
			
	Issued Share Capital	 	:	  	100,000,000 ordinary shares;
			
		 		  	43,685,079 Series A Preferred Shares; and
			
		 		  	124,224,883 Series B Preferred Shares.
			
	Shareholders	 	:	  	See Exhibit D-1
			
	Directors	 	:	  	CHAN Yi Sing, CAO Xiaofeng, TIAN Guan Yong, Zhai Pu, ZHU Jian Huan, John Lawrence WALECKA, GOH Yin Long
			
	Company Secretary	 	:	  	N/A
			
	Registered Agent	 	:	  	Offshore Incorporations (Cayman) Limited

 Schedule IV 
 Particulars of the Subsidiaries 
 CGEN HK 
  

							
	Name	 	:	  	CGen Media Technology Company Limited	  	
				
	Place of Incorporation	 	:	  	Hong Kong	  	
				
	Registration No.	 	:	  	875785	  	
				
	Date of Incorporation	 	:	  	17 December 2003	  	
			
	Registered Address	 	:	  	Unit 1, 6/F, Grand City Plaza, 1-17 Sai Lau Kok Road, Tsuen Wan New Territories, Hong Kong
				
	Authorised Share Capital	 	:	  	HK$10,000	  	
				
	Issued Share Capital	 	:	  	HK$10,000	  	
				
	Shareholders	 	:	  	Name	  	Percentage of Shares held
		 		  	CGen Digital Media Co., Limited	  	100%
			
	Directors	 	:	  	CHAN Yi Sing, TIAN Guanyong (

), CAO Xiao Feng (

), ZHAI Pu (

), GOH Yin Long, ZHU Jian Huan, LIN Chi Ju Tina as alternate director to Goh Yin Long, CHAN Chun Hung Vincent as alternate director to ZHU Jian Huan
				
	Company Secretary	 	:	  	CorpiSs Limited	  	

 Schedule IV Continued 
 WFOE 
  

			
	Name:	  	CGEN Digital Technology (Shanghai) Co., Ltd.
		
	Approval Number:	  	Shangwaizihuzhangduzi Zi (2005) No. 1260
		
	Registration Number:	  	Qiduhupuzong Zi No. 320829 (Pudong)
		
	Nature of Enterprise:	  	WFOE
		
	Place of Incorporation:	  	Room 2207, No. 200 Zhangheng Road, Zhangjiang High-Tech Park, Shanghai
		
	Total Investment:	  	US$29.5 million
		
	Registered Capital:	  	US$19.5 million
		
	Paid-up Registered Capital:	  	US$11.9 million
		
	Registered Office:	  	Room 2207, No. 200 Zhangheng Road, Zhangjiang High-Tech Park, Shanghai
		
	Business Scope:	  	Design, develop, produce and sell self-produced products, provide relevant technology consulting services regarding design, test and maintenance of computer system integration
		
	Date of Incorporation:	  	29 August 2005
		
	Operating Term:	  	20 Years
		
	Legal Representative:	  	CHAN Yi Sing
		
	General Manager:	  	CHAN Yi Sing
		
	Branches and Subsidiaries:	  	N/A

 List of Shareholders and Percentage of Equity Interest: 
  

							
	 Name of Shareholder
	  	 Contribution
	  	Form of
Contribution	  	Percentage (%)
	 CGEN Media Technology Co., Ltd.
	  	US$11.9 million paid-up	  	cash	  	100
		  		  		  	 
	 TOTAL
	  		  		  	100
		  		  		  	 

 Schedule IV Continued 
 OpCo 
  

			
	Name:	  	Shanghai CGEN Digital Media Network Co., Ltd. ([GRAPHIC])
		
	Registration Number:	  	3101052006762
		
	Nature of Enterprise:	  	Company Limited (domestic joint venture)
		
	Place of Incorporation:	  	Room A, Floor 4, North Building, Dingxi Road, Changning District, Shanghai
		
	Registered Capital:	  	RMB 20 million
		
	Paid-up Registered Capital:	  	RMB 20 million
		
	Registered Office:	  	Room A, Floor 4, North Building, Dingxi Road, Changning District, Shanghai
		
	Business Scope:	  	Culture and art consulting, commercial consulting and meeting service, design, produce, act as agent and release national and international advertisement business. (in accordance with the
administration license if required )
		
	Date of Incorporation:	  	September 10, 2003
		
	Operating Term:	  	Ten years
		
	Legal Representative:	  	Xiaofeng Cao
		
	General Manager:	  	Xiaofeng Cao
		
	Branches and Subsidiaries:	  	 Beijing Affiliate
 Guangzhou
Affiliate

 List of Shareholders and Percentage of Equity Interest: 
  

							
	 Name of Shareholder
	  	Contribution (RMB)	  	Form of
Contribution	  	Percentage (%)
	 Weiming Gao [GRAPHIC]
	  	9.9 million	  	cash	  	49.5
	 Xiaofeng Cao 

	  	3.6 million	  	cash	  	18
	 Haiguang Zhu 

	  	1.8 million	  	cash	  	9
	 Guanyong Tian 

	  	2 million	  	cash	  	10
	 Fang Yao 

	  	2.7 million	  	cash	  	13.5
		  	 	  		  	 
	 TOTAL
	  	20 million	  		  	100
		  	 	  		  	 

 Schedule V 
 Leased Property 
 1. Address: Room 3293-94, Tower B, City Center of Shanghai, No.100 Zunyi Road, Shanghai
200051 China 
 Duration: 15 August 2005 to 14 August 2007 
 Landlord: LONGVIEW ASSETS LIMITED 
 2. Address: Room 1805,
Full Tower, No. 9 Dong San Huan Zhong Road, Zhaoyang District, Beijing 
 Duration: 22 Sept. 2005 to 21 Sept. 2007 
 Landlord: Runze Dong 
 3. Address: 9E, No., West Tiyu Road,
Guangzhou 
 Duration: 1 Nov. 2006 to 31 Oct. 2007 
 Landlord: Guangzhou Gaosheng Property Management Development Co., Ltd. 

 Schedule VI 
 Key Employees 
  

			
	Founders:	  	 Yising Chan
 Tian Guanyong
 Cao Xiaofeng
 Zhu Haiguang
 Yao Fang

		
	Senior Managers and Key Technical Employees:	  	 CEO: Mei Lijun
 COO: Cao Zhigao
 CFO: Hu Yufei
 Vice Presidents:
 Zhu Wei
 Fang Sheng
 Hu Xiaotu

 Schedule VII 
 Convertible Notes 
  

									
	 Holder
	  	Amount of the
Convertible Notes	  	Conversion Price	  	Number of
Series C
Preferred Shares
issued upon
Conversion
	 REDPOINT VENTURES II, L.P.
	  	US$	866,310.49	  	US$	0.20357356	  	4,255,516
	 REDPOINT ASSOCIATES II, LLC
	  	US$	20,031.34	  	US$	0.20357356	  	98,399
	 TDF CAPITAL CHINA II, LP
	  	US$	900,691.32	  	US$	0.20357356	  	4,424,402
	 TDF CAPITAL ADVISORS, LP
	  	US$	38,703.06	  	US$	0.20357356	  	190,118
	 JAFCO ASIA TECHNOLOGY FUND III
	  	US$	1,073,593.56	  	US$	0.20357356	  	5,273,738
	 SUMITOMO CORPORATION EQUITY ASIA LIMITED
	  	US$	563,873.46	  	US$	0.20357356	  	2,769,876
	 HUITUNG INVESTMENTS (BVI) LIMITED
	  	US$	536,796.78	  	US$	0.20357356	  	2,636,869
		  	 	 	  			  	 
	 TOTAL
	  	 	4,000,000.01	  			  	19,648,918
		  	 	 	  			  	 

 Schedule VIII 
 Warrants 
  

									
	 Holder
	  	Number of Series B
Preferred Shares
Issued upon
Exercise	  	Exercise Price Per
Series B Share	  	Purchase Price
	 REDPOINT VENTURES II, L.P.
	  	763,929	  	US$	0.113402	  	US$	86,631.08
	 REDPOINT ASSOCIATES II, LLC
	  	17,664	  	US$	0.113402	  	US$	2,003.13
	 TDF CAPITAL CHINA II, LP
	  	794,247	  	US$	0.113402	  	US$	90,069.20
	 TDF CAPITAL ADVISORS, LP
	  	34,129	  	US$	0.113402	  	US$	3,870.30
	 JAFCO ASIA TECHNOLOGY FUND III
	  	946,716	  	US$	0.113402	  	US$	107,359.49
	 SUMITOMO CORPORATION EQUITY ASIA LIMITED
	  	497,235	  	US$	0.113402	  	US$	56,387.44
	 HUITUNG INVESTMENTS (BVI) LIMITED
	  	473,358	  	US$	0.113402	  	US$	53,679.74
		  	 	  			  	 	 
	 TOTAL
	  	3,527,278	  			  	US$	400,000.38
		  	 	  			  	 	 

 Schedule IX 
 Notice Schedule 
 CPI Ballpark Investments Ltd. 
 c/o Merrill Lynch (Asia Pacific) Limited 
 17th Floor, ICBC Tower 

3 Garden Road 
 Central, Hong Kong 
  

			
	Tel:	  	852 2161 7650
	Fax:	  	852 2161 7148
	Attention:	  	Sampson Lew

 TDF Capital China II, LP 
 TDF Capital Advisors, LP 
 Unit 2505, K. WAH Center 
 1010 Huaihai Zhong Road 
 Shanghai 200031 
 People’s Republic of China 
  

			
	Fax:	  	+86 (21) 5404-7557
	Attention:	  	Ian Goh

 Redpoint Ventures II, L.P. 
 Redpoint Associates II, LLC 
 3000 Sand Hill Road 
 Building 2, Suite 290 
 Menlo Park, CA 94025 
  

			
	Fax:	  	650 854 5762
	Attention:	  	John L. Walecka

 EXHIBIT A 
 FORM OF THIRD AMENDED AND RESTATED MEMORANDUM 
 AND ARTICLES OF ASSOCIATION 
 (see TAB 4) 

 EXHIBIT B 
 FORM OF SHAREHOLDERS’ AGREEMENT 
 (see TAB 2) 

 EXHIBIT C 
 FORM OF REGISTRATION RIGHTS AGREEMENT 
 (see TAB 3) 

 EXHIBIT D-1 
 SHAREHOLDERS AND PERSONS HOLDING OPTIONS, WARRANTS, ETC. 
 IMMEDIATELY PRIOR TO THE CLOSING 

  

											
	 Shareholders
	  	Series A
Preferred
Shares	  	Series B
Preferred
Shares	  	Ordinary
Shares	  	Total Issued
Shares	  	Warrants
to
Purchase
Series B
Preferred
Shares
	 Chan Yi Sing
	  		  		  	97,087,661	  	97,087,661	  	
	 Totnes International Limited
	  		  		  	2,912,339	  	2,912,339	  	
	 S.I. Technology Venture Capital Limited
	  	33,977,284	  		  		  	33,977,284	  	
	 Sumitomo Corporation Equity Asia Limited
	  	9,707,795	  	8,818,196	  		  	18,525,991	  	497,235
	 JAFCO Asia Technology Fund III
	  		  	35,272,780	  		  	35,272,780	  	946,716
	 TDF Capital China II, LP
	  		  	29,592,099	  		  	29,592,099	  	794,247
	 TDF Capital Advisors, LP
	  		  	1,271,584	  		  	1,271,584	  	34,129
	 Huitong Investments (BVI) Limited
	  		  	17,636,390	  		  	17,636,390	  	473,358
	 Redpoint Ventures II, L.P.
	  		  	28,462,521	  		  	28,462,521	  	763,929
	 Redpoint Associates II, LLC
	  		  	658,127	  		  	658,127	  	17,664
	 Investlink Consulting (China) Limited
	  		  	2,513,186	  		  	2,513,186	  	
	 ESOP
	  		  		  	23,296,518	  		  	
		  	 	  	 	  	 	  	 	  	 
	 Total
	  	43,685,079	  	124,224,883	  	123,296,518	  	267,909,962	  	3,527,278
		  	 	  	 	  	 	  	 	  	 

 EXHIBIT D-2 
 SHAREHOLDERS AND PERSONS HOLDING OPTIONS, WARRANTS, ETC. 
 ASSUMING COMPLETION OF THE CLOSING 

  

											
	 Shareholders
	  	Series A
Preferred
Shares	  	Series B
Preferred
Shares	  	Series C
Preferred
Shares	  	Ordinary
Shares	  	Total Issued
Shares
	 Chan Yi Sing
	  		  		  		  	89,719,317	  	89,719,317
	 Totnes International Limited
	  		  		  		  	2,912,339	  	2,912,339
	 S.I. Technology Venture Capital Limited
	  	33,977,284	  		  		  		  	33,977,284
	 Sumitomo Corporation Equity Asia Limited
	  	9,707,795	  	9,315,431	  	2,769,876	  		  	21,793,102
	 JAFCO Asia Technology Fund III
	  		  	36,219,496	  	5,273,738	  		  	41,493,234
	 TDF Capital China II, LP
	  		  	30,386,346	  	16,013,474	  		  	46,399,820
	 TDF Capital Advisors, LP
	  		  	1,305,713	  	688,106	  		  	1,993,819
	 Huitong Investments (BVI) Limited
	  		  	18,109,748	  	2,636,869	  		  	20,746,617
	 Redpoint Ventures II , L.P.
	  		  	29,226,450	  	16,324,124	  		  	45,550,574
	 Redpoint Associates II, LLC
	  		  	675,791	  	377,456	  		  	1,053,247

											
	 Shareholders
	  	Series A
Preferred
Shares	  	Series B
Preferred
Shares	  	Series C
Preferred
Shares	  	Ordinary
Shares	  	Total Issued
Shares
	 Investlink Consulting (China) Limited
	  		  	2,513,186	  		  		  	2,513,186
	 CPI Ballpark Investments Ltd
	  		  		  	73,683,439	  		  	73,683,439
	 ESOP
	  		  		  		  	23,296,518	  	
		  	 	  	 	  	 	  	 	  	 
	 Total
	  	43,685,079	  	127,752,161	  	117,767,082	  	92,631,656	  	381,835,978
		  	 	  	 	  	 	  	 	  	 

 EXHIBIT E 
 BUSINESS PLAN 

 EXHIBIT F 
 FORM OF OPINION OF COMPANY’S CAYMAN ISLANDS COUNSEL 
 (see TAB 10) 

 EXHIBIT G 
 FORM OF OPINION OF COMPANY’S PRC COUNSEL 
 (see TAB 11) 

 EXHIBIT H 
 FORM OF EMPLOYMENT AGREEMENT 
 (see TAB 21) 

 EXHIBIT I 
 FORM OF INTELLECTUAL PROPERTY LICENSE AGREEMENTS 
 (see TAB 22) 

 EXHIBIT J 
 FORM OF INDEMNIFICATION AGREEMENT 
 (see TAB 6) 

 EXHIBIT K 
 FORM OF INTELLECTUAL PROPERTY TRANSFER AGREEMENTS 
 (see TAB 23) 

 EXHIBIT L 
 FORM OF TAX INDEMNITY AGREEMENT 
 (see TAB 5)Shareholders Agreement, dated as of December 7, 2006

 Exhibit 4.12 
  

 SHAREHOLDERS’ AGREEMENT 
 DATED AS OF DECEMBER 7, 2006 
  

  

 1 

 Table of Contents 
  

					
	 Section 1.
	  	Definitions	  	4
			
	 Section 2.
	  	Limitations on Transfers of Shares by Ordinary Shareholders	  	7
			
	 Section 3.
	  	Investors’ Right of First Refusal	  	8
			
	 Section 4.
	  	Right of Co-Sale	  	8
			
	 Section 5.
	  	Required Sale	  	11
			
	 Section 6.
	  	Pre-emptive Rights	  	12
			
	 Section 7.
	  	Information Rights	  	14
			
	 Section 8.
	  	Directors and Management	  	15
			
	 Section 9.
	  	Legend on Share Certificates	  	19
			
	 Section 10.
	  	Additional Shares	  	19
			
	 Section 11.
	  	Covenants	  	19
			
	 Section 12.
	  	Severability; Governing Law; Dispute Resolution	  	26
			
	 Section 13.
	  	Successors and Assigns	  	27
			
	 Section 14.
	  	Notices	  	27
			
	 Section 15.
	  	Modification; Assignment	  	28
			
	 Section 16.
	  	Headings	  	29
			
	 Section 17.
	  	Nouns and Pronouns	  	29
			
	 Section 18.
	  	Entire Agreement	  	29
			
	 Section 19.
	  	Confidentiality and Announcements	  	29
			
	 Section 20.
	  	Several Liability of Investors	  	32
			
	 Section 21.
	  	Investor Rights	  	32
			
	 Section 22.
	  	Counterparts	  	32

  

 2 

 EXECUTION COPY 
 SHAREHOLDERS’ AGREEMENT 
 THIS SHAREHOLDERS’ AGREEMENT (this “Agreement”) dated as
of December 7, 2006, is made by and among CGEN Digital Media Company Limited, an exempted company with limited liability under the laws of the Cayman Islands (the “Company”), CGEN Media Technology Co., Ltd., a company
organized under the laws of Hong Kong (“CGEN HK”), CGEN Digital Technology (Shanghai) Co., Ltd., a wholly foreign-owned enterprise organized under the laws of the People’s Republic of China (together with CGEN HK, the
“Subsidiaries” and each a “Subsidiary”), Shanghai CGEN Digital Media Network Co., Ltd., a company organized under the laws of the People’s Republic of China (“OpCo”), Chan
Yi Sing (Singapore NRIC No. S1306068A), Tian Guanyong (

) (PRC ID No. 133031651224065), Cao Xiaofeng (

) (PRC ID No. 310112197008270052), Yao Fang (

) (PRC ID No. 310221670521081) and Zhu Hai Guang (

) (PRC ID No. 410423197106070010) (together with Chan Yi Sing, Tian Guanyong (

), Cao Xiaofeng (

) and Yao Fang (

), the “Founders”, and each a “Founder”), and the Shareholders of the Company identified on Schedule I hereto (each, a “Shareholder” and,
collectively, the “Shareholders”). 
 RECITALS 
 WHEREAS pursuant to the terms of that certain Shareholders’ Agreement (the “Prior Agreement”) dated February 10,
2006, by and among the Company and the Shareholders party thereto, the Company and such Shareholders agreed upon the terms and conditions for certain Transfers of Shares, voting of Shares and the continuity and stability of the business and policies
of the Company; 
 WHEREAS, the Company and the Shareholders party to the Prior Agreement desire to terminate the Prior Agreement and
to accept the rights created pursuant hereto in lieu of the rights granted to them under the Prior Agreement; 
 WHEREAS, each
Shareholder owns, on the date hereof, that number of Shares set forth opposite such Shareholder’s name on Schedule I hereto; and 
 WHEREAS, it is deemed to be in the best interest of the Company and the Shareholders that provision be made for certain Transfers of Shares, voting of Shares and the continuity and stability of the business and policies of the
Company, and, to that end, the Company and the Shareholders hereby set forth their agreement with respect to the Shares owned by the Shareholders. 
 NOW, THEREFORE, in consideration of the premises and of the mutual consents and obligations hereinafter set forth, the parties hereto hereby agree as follows: 
  

 3 

 Section 1. Definitions. 
 As used herein, the following terms shall have the following respective meanings: 
 “Affiliate” means, with respect to any Person, any of (a) a director, officer or partner of such Person, (b) a spouse, parent, sibling or descendant of such Person or a spouse, parent, sibling or descendant
of a director, officer, or partner of such Person and (c) any other Person that, directly or indirectly, through one or more intermediaries, controls, or is controlled by, or is under common control with, another Person; and in the case of an
Investor, shall include (i) any Person who holds Shares as a nominee for such Investor, (ii) any shareholder of such Investor, (iii) any entity or individual which has a direct and indirect interest in such Investor (including, if
applicable, any general partner or limited partner) or any fund manager thereof; (iv) any Person that directly or indirectly controls, is controlled by, under common control with, or is managed by such Investor or its fund manager, (v) the
relatives of any individual referred to in (iii) above, and (vi) any trust controlled by or held for the benefit of such individuals. For the avoidance of doubt, no Investor shall be deemed to be an Affiliate of any Member of Company Group
or of OpCo. The term “control” includes, without limitation, the possession, directly or indirectly, of the power to direct the management and policies of a Person, whether through the ownership of voting securities, by contract or
otherwise. Without limiting the generality of the above, the term “Affiliate” in the case of CPI Ballpark Investments Ltd. shall include any Affiliate of Merrill Lynch (Asia Pacific) Limited. 
 “Board” means the Board of Directors of the Company. 
 “Charter” shall mean the Third Amended and Restated Memorandum and Articles of Association of the Company, as amended from time
to time pursuant to the provisions of this Agreement. 
 “Company Group” shall mean the Company, each Subsidiary,
OpCo, and any of their respective subsidiaries from time to time, and “Member of the Company Group” means any of them. 
 “Company Sale” shall have the meaning set forth in the Charter. 
 “Competitor” shall mean any business operator identified on Schedule II hereto, which the Company may, with the consent of the Investors, update annually
and provide to the Investors, provided that, at any time, such list may consist of not more than three of those domestic PRC business operators that directly engage in narrowcast out-of-home advertising and are actual competitors and/or have
a similar customer base as that of the Company Group in the markets in the PRC in which the Company Group operates in respect of its principal business. 
 “Co-Sale Proportionate Percentage”, with respect to any Investor, means the ratio of: (a) the total number of Ordinary Share Equivalents held by that Investor to (b) the total number
of Ordinary Share Equivalents held by the Transferring Shareholder and all Investors exercising the Co-Sale Right pursuant to Section 4. 
 “Final Post-Money Valuation” shall have the meaning set forth in the Charter. 
 “Fully-Diluted Proportionate Percentage for Co-Sale to a Competitor” with respect to any Shareholder, means the ratio of (a) the total number of Ordinary Share Equivalents held by that Shareholder to
(b) the total number of Ordinary Share Equivalents owned by all shareholders at the date of determination. 
  

 4 

 “IFRS” shall mean International Financial Reporting Standards as promulgated from
time to time by the International Accounting Standards Board as applied on a consistent basis. 
 “Investors” shall
mean the Persons identified as such on Schedule I hereto, and shall include any successor to, or assignee or transferee of any the Investors who shall agree in writing to be treated as an Investor and to be bound by the terms and to comply
with the provisions of this Agreement. 
 “Investor Directors” shall mean the Series C Director and the Series B
Directors and “Investor Director” means any of them. 
 “Investor Observer” means any
observer appointed by any Investor to the Board or the board of directors of any Subsidiary. 
 “Investor Proportionate
Percentage” with respect to any Investor, means the ratio of (a) the total number of Ordinary Share Equivalents held by that Investor on the date of the Transfer Notice to (b) the total number of Ordinary Share Equivalents
held by all Investors. 
 “OpCo Board” shall mean the board of directors and each committee thereof, of Shanghai CGEN
Digital Media Network Co., Ltd., a company organized under the laws of the People’s Republic of China. 
 “Ordinary Share
Equivalents” means the number of issued and outstanding Ordinary Shares, and Ordinary Shares into which issued and outstanding Preferred Shares (as adjusted in accordance with their terms) and other securities are convertible from time
to time. 
 “Ordinary Shares” shall mean the ordinary shares, par value US$0.000001, in the capital of the Company.

 “Ordinary Shareholder” shall mean any Shareholder that is not an Investor. For the avoidance of doubt, each
Founder is an Ordinary Shareholder for the purpose of this Agreement. 
 “Person” shall mean any individual,
partnership, corporation, group, trust or other legal entity. 
 “Preferred Shares” shall mean collectively the
Series A Preferred Shares, the Series B Preferred Shares and the Series C Preferred Shares. 
 “PRC” shall mean the
People’s Republic of China and, for the purpose of this Agreement, excluding Hong Kong Special Administrative Region, Macau Special Administrative Region and the Islands of Taiwan. 
  

 5 

 “Preferred Supermajority” shall mean, at any point in time, holders representing
in the aggregate not less than two-thirds (2/3) of the outstanding Preferred Shares, voting together as a single class, at such time on an as converted basis. 
 “Pro Rata Share” shall mean, with respect to any Shareholder, the ratio of (a) the total number of Ordinary Share Equivalents held by that Shareholder immediately before the proposed
allotment and issue of New Securities to (b) the total number of Ordinary Share Equivalents outstanding immediately before the proposed allotment and issue of New Securities. 
 “Qualified Public Offering” shall have the meaning set forth in the Charter. 
 “Senior Manager” means, with respect to any Member of Company Group, the chief executive officer of such company and any member
of management reporting directly to the board of directors or other management employees at the level of vice president and above. 
 “Series A Director” shall have the meaning ascribed thereto in Section 8.B. 
 “Series A Preferred Shares” shall mean Series A Redeemable Convertible Preferred Shares, par value US$0.000001, in the capital of the Company. 
 “Series B Preferred Shares” shall mean Series B Redeemable Convertible Preferred Shares, par value US$0.000001, in the capital of
the Company. 
 “Series B Director” shall have the meaning ascribed thereto in Section 8.B. 

“Series C Conversion Shares” shall mean the Ordinary Shares issued upon the conversion of the Series C Preferred
Shares. 
 “Series C Preferred Shares” shall mean Series C Redeemable Convertible Preferred Shares, par value
US$0.000001, in the capital of the Company. 
 “Series C Director” shall have the meaning ascribed thereto in
Section 8.B. 
 “Shares” shall mean (i) the presently issued and outstanding Ordinary Shares and
Preferred Shares and any options or share subscription warrants exercisable therefor (which options and warrants shall be deemed to be that number of outstanding Shares for which they are exercisable), (ii) any additional share capital of the
Company hereafter issued and outstanding and (iii) any share capital of the Company into which such shares may be converted or for which they may be exchanged or exercised. 
 “Shareholders” shall mean the Persons identified as such on Schedule I hereto, and shall include any successor to, or
assignee or transferee of any of the Shareholders who shall agree in writing to be treated as a Shareholder and to be bound by the terms and to comply with the provisions of this Agreement. 
  

 6 

 “Transfer”, as to any Share shall mean to sell, or in any other way transfer,
assign, pledge, distribute, encumber or otherwise dispose of, such Share, either directly or indirectly, voluntarily or involuntarily and with or without consideration. 
 “Transaction Documents” shall mean the CGEN Digital Media Company Limited Series C Preferred Shares Purchase Agreement dated December 5, 2006, the Charter, this Agreement and the
Registration Rights Agreement dated the date hereof. 
 Section 2. Limitations on Transfers of Shares by Ordinary Shareholders. 
 A. The Ordinary Shareholders shall not, at any time during the term of this Agreement, transfer any Shares (including, without limitation, any
Shares held in trust for any other Shareholder or by any other Shareholder) without first complying with the provisions of Section 3, Section 4 and Section 5; provided, that the restrictions with respect to
Transfers set forth in Section 3, Section 4 and Section 5 shall not, subject to any applicable law, apply to any transfer by any Ordinary Shareholder who is a natural person: 
 (i) to a legal representative of such Ordinary Shareholder, if such Ordinary Shareholder becomes incapacitated, or upon the death of such
Shareholder; 
 (ii) by will, the laws of intestacy or the laws of descent or survivorship; or 
 (iii) any sale or transfer of Shares to the Company or an entity designated by the Company pursuant to a repurchase right or right of
first refusal of the Company in the event of a termination of an employment or consulting relationship with a Member of Company Group; or 
 (iv) any transfer by a Founder to his or her children who is capable of being bound under an Adherence Agreement, or to trusts for the benefit of such persons, for bona fide estate planning purposes; 
 (v) pursuant to a court order upon the termination of a marital relationship of such Ordinary Shareholder: 
 (vi) any transfer by an Ordinary Shareholder to an Investor pursuant to Article 8(e) of the Charter. 
 B. Any permitted transferee listed above is hereinafter referred to a “Permitted Transferee”; provided,
however, that in the case of any transfer described in Section 2.A above: (x) each Permitted Transferee shall have executed and delivered to the Company and the other Shareholders, as a condition precedent to any such
transfer or acquisition of Shares, an Adherence Agreement in the form of Exhibit A and shall submit to the Company and the Investors such evidence as the Company and the Investors may reasonably request to demonstrate that such transferee
qualifies as a Permitted Transferee and (y) each Permitted Transferee shall remain qualified as a Permitted Transferee of the Transferring Shareholder at all times following such transfer for as long as it continues to hold any Shares, failing
which it shall transfer the Shares held by it to another Permitted Transferee reasonably satisfactory to the Company and the Investors. 
  

 7 

 Section 3. Investors’ Right of First Refusal. 
 A. Except as otherwise provided in Section 2, each Ordinary Shareholder hereby agrees that he or it shall not Transfer any Shares,
except in accordance with the procedures set forth in this Section 3 and Section 4. 
 B. With Respect to
Shares Owned by Ordinary Shareholders. 
 (i) Transfer Notice of Sale. Any Ordinary Shareholder (a
“Transferring Shareholder”) may not Transfer any Shares held by it or him (the “Transfer Shares”) unless it complies with this Section 3 and with Section 4. The Transferring
Shareholder shall promptly give written notice (the “Transfer Notice”) to the Company and to each Shareholder describing in reasonable detail the proposed Transfer including, without limitation, the number of Transfer Shares,
the nature of such Transfer, the consideration to be paid, and the name and the address of each prospective purchaser or transferee. (The right of first refusal of an Investor under this Section 3.B is hereinafter referred to as the
“Right of First Refusal”). 
 (ii) Notice of Purchase. Each Investor shall have 45 days from
the date of receipt of the Transfer Notice to agree to purchase all or any part of such Investor’s Investor Proportionate Percentage of the Transfer Shares for the price and upon the terms and conditions specified in the Transfer Notice (or the
actual terms of the proposed transfer, if more favorable to the proposed transferee), by giving written notice to the Transferring Shareholders stating therein the number of Transfer Shares to be purchased. A failure by an Investor to respond within
such 45 day period shall be deemed a decision by such Investor not to exercise its right to purchase any of the Transfer Shares. 
 (iii) Non-Exercise. Subject to the provisions of Section 4, in the event the Investor(s) fail to agree to purchase all of the Transfer Shares within the respective periods given above, the Transferring Shareholder shall,
within 90 days of delivery of the Transfer Notice to the Company and the Investors, Transfer the Transfer Shares not purchased hereunder, on terms no more favorable to the transferee than specified in the original Transfer Notice. In the event that
the Transferring Shareholder has not sold the Transfer Shares within such 90-day period, the Transferring Shareholder shall not thereafter Transfer any Shares without again offering such Shares to the Investors in the manner provided in clause
(i) above. 
 Section 4. Right of Co-Sale. 
 A. Co-Sale Right. Any notice of exercise of the Co-Sale Right shall specify the number of the Shares such Investor wishes to Transfer under its Co-Sale Right. Any Investor may elect to Transfer all or
some of the Shares then held by such Investor up to 

  

 8 

 
that Investor’s Co-Sale Proportionate Percentage with respect to its Shares. Each Investor who does not exercise its Right of First Refusal pursuant to
Section 3 above shall have the right, exercisable upon written notice to the Transferring Shareholder within 45 days after the date the Transfer Notice is delivered to the Investors, to participate in the Transfer of Shares on
substantially the same terms and conditions as the Transferring Shareholder to the extent of that Investor’s Co-Sale Proportionate Percentage with respect to its Shares (the “Co-Sale Right”), provided,
however, such Co-Sale Right shall not apply to any Transfer of Shares to an Investor pursuant to the exercise of the Right of First Refusal of such Investor under Section 3. To the extent the Investors exercise their Co-Sale Right
in accordance with the terms and conditions set forth in this Section 4, the Transferring Shareholder may only sell its Shares if the proposed transferee completes the purchase of the shares which the Investors seek to sell pursuant to
the exercise of their Co-Sale Right, and shall, at the request of any Investor, reduce the number of its Shares to be sold by the number of Shares that such Investor wishes to sell under its Co-Sale Right. 
 B. Delivery of Certificates. The Investors shall effect their participation in the Transfer by promptly delivering to the Transferring
Shareholder for transfer to the prospective purchaser one or more certificates, properly endorsed for transfer, which represent the type and number of Shares which the Investors elect to sell; provided that if an Investor elects to sell
Preferred Shares under its Co-Sale Right, it shall convert such Preferred Shares into Ordinary Shares for transfer prior to consummation of the Transfer. No Co-Sale Investor shall be required to give any representations and warranties to the
purchaser other than a representation and warranty that such Shares are sold by such Investor as beneficial owner free from liens other than those under this Agreement and the Charter. 
 C. Sales Proceeds. The share certificate or certificates that the Investors deliver to the Transferring Shareholder pursuant to
Section 4.A shall be transferred to the prospective purchaser in consummation of the Transfer of the Shares pursuant to substantially the same terms and conditions as specified in the Transfer Notice, and the Transferring Shareholder
shall upon receiving the same from the prospective purchaser concurrently remit to each Investor that portion of the sale proceeds to which that Investor is entitled by reason of its participation in the Transfer. To the extent that any prospective
purchaser or purchasers prohibits assignment or otherwise refuses to purchase shares or other securities from the Investors, the Transferring Shareholder shall not sell to the prospective purchaser or purchasers any Shares unless and until, prior to
or simultaneously with the Transfer, the Transferring Shareholder causes the purchase of those shares or other securities from the Investors, provided, however, that notwithstanding the limitation of Section 4.A, if any
Shareholder (regardless of whether such Shareholder is an Ordinary Shareholder or an Investor) proposes to Transfer Shares to any Competitor, each Shareholder other than such Transferring Shareholder shall have the Co-Sale Right set forth in this
Section 4, applied with such modifications as may be necessary for it to Transfer its Fully-Diluted Proportionate Percentage for Co-Sale to a Competitor to the prospective purchaser. 
  

 9 

 D. Sale by Transferring Shareholder. Subject to as hereinafter provided, if and to the
extent that the Investors do not exercise their Right of First Refusal or their Co-Sale Right in aggregate with respect to the Transfer of all the Shares subject to the Transfer Notice within the relevant prescribed period, the Transferring
Shareholder may, not later than 90 days following delivery to the Company and the Investors of the Transfer Notice, conclude a bona fide Transfer of all of the Shares covered by the Transfer Notice on terms no more favorable to the transferee or
transferor than set forth in the Transfer Notice. Any proposed Transfer on terms more favorable than set forth in the Transfer Notice, as well as any subsequent proposed Transfer of any Shares by the Transferring Shareholder, shall again be subject
to the Right of First Refusal and Co-Sale Right of the Investors and shall require compliance by the Transferring Shareholder with the procedures described in this Section 4. 
 E. No Adverse Effect. Any Investor’s exercise or non-exercise of the Right of First Refusal or the Co-Sale Right shall not adversely
affect its rights to participate in subsequent Transfers of Shares by a Transferring Shareholder subject to the provisions of this Section 4. 
 F. Prohibited Transfer. In the event a Transferring Shareholder Transfers or attempts to Transfer any Shares in contravention of the Right of First Refusal or the Co-Sale Right of the Investors, or any
Shareholder Transfers or attempts to Transfer any Shares otherwise in contravention of Section 4 or Section 3 (a “Prohibited Transfer”), such transfer or attempted transfer shall be invalid and of no
effect and the Company will not effect any attempt to Transfer Shares in violation of Section 4 or Section 3 nor will it treat any alleged transferee as the holder of the Shares purported to be transferred in violation of
Section 4 or Section 3. Each Investor, in addition to other remedies as may be available at law, in equity or hereunder, shall have the put option provided in Section 4.G below, and the Transferring Shareholder
shall be bound by the applicable provisions of that put option. 
 G. Remedies. In the event of a Prohibited Transfer, the
Investors shall have the right to sell to the Transferring Shareholder the type and number of Shares equal to the number of Shares the Investors would have been entitled to Transfer to the purchaser had the Prohibited Transfer been effected pursuant
to and in compliance with the terms of this Agreement (the “Put Option”). Such sale shall be made on the following terms and conditions: 
 (i) the price per share at which the Shares are to be sold to the Transferring Shareholder shall be equal to the price per share paid in
the Prohibited Transfer; 
 (ii) the Transferring Shareholder shall reimburse the Investors for any and all fees and expenses,
including legal fees and expenses, incurred pursuant to the exercise or the attempted exercise of the Investors’ rights under this Section 4; 
  

 10 

 (iii) within 60 days after the earlier of the dates on which the Investors
(i) receive notice of the Prohibited Transfer, or (ii) otherwise become aware of the Prohibited Transfer, the Investors shall, if exercising the Put Option created by this Section 4.G, deliver to the Transferring Shareholder
the certificate or certificates representing the Shares to be sold, each certificate to be properly endorsed for transfer or accompanied by duly executed transfer instruments; 
 (iv) the Transferring Shareholder shall, upon receipt of the certificate or certificates for the Shares to be sold by the Investors,
pursuant to this Section 4.G, pay the aggregate purchase price therefor and the amount of reimbursable fees and expenses, as specified in Section 4.G(ii), in cash or by other means acceptable to the Investors; and 

(v) notwithstanding the foregoing, the Company agrees it will not effect any attempt by the Transferring Shareholder to Transfer Shares
in violation of Section 3 and Section 4 nor will it treat any alleged transferee as the holder of the Shares purported to be transferred in violation of Section 3 and Section 4, unless the exercise of
the Put Option has been completed pursuant to this Section 4.G). Anything contained herein to the contrary notwithstanding, the Transferring Shareholder shall, in addition to complying with the provisions of this Section 4,
comply with the provisions of Section 3 (it being understood that the Transfer Notice contemplated by Section 3.A shall include the notice of Co-Sale Right), and each Ordinary Shareholder, prior to Transferring any Shares to
the prospective purchaser, shall comply with the provisions of Section 3. 
 (vi) Anything contained herein to the
contrary notwithstanding, (x) any Transferring Shareholder shall submit to the Company and the Investors such evidence as the Company and the Investors may reasonably request to demonstrate that such transferee qualifies as a Permitted
Transferee, and each Permitted Transferee shall remain qualified as a Permitted Transferee of the Transferring Shareholder at all times following such Transfer for as long as it continues to hold any Shares, failing which it shall transfer the
Shares held by it to another Permitted Transferee reasonably satisfactory to the Company and the Investors. 
 Section 5. Required Sale.

 Anything contained herein to the contrary notwithstanding, if at any time the Preferred Supermajority, who also hold not less than ten
percent (10%) of the Ordinary Share Equivalents, and the holders who hold at least two-thirds (2/3) of the issued and outstanding Ordinary Shares, shall approve (i) a bona fide arms length proposal from a Person for the transfer,
directly or indirectly, of all of the shares of the Company to such Person, (ii) the merger or consolidation of the Company with or into another Person in which the shareholders of the Company will receive cash or securities of any other Person
for their shares under circumstances in which holders of a majority in voting power of the share capital of the Company immediately prior to such transaction beneficially own less than a majority in voting power of the outstanding share capital of
the Company, or the surviving or resulting corporation or acquirer, as the case may be, immediately following such transaction, or (iii) the sale by the Company or its 

  

 11 

 
subsidiaries of all or substantially all of their assets to a Person, in each of the above cases for a specified price payable in cash or otherwise and on
specified terms and conditions (a “Sale Proposal”), and if such Sale Proposal has been endorsed by shareholders of the Company holding not less than a majority of the Ordinary Share Equivalents voting together
as a single class, then such shareholders (or their designated representative) may deliver a notice (a “Required Sale Notice”) with respect to such Sale Proposal to each other Shareholder (as well as each other
holder of any shares) stating that such shareholders have approved or propose to effect the Sale Proposal and providing the identity of the Persons involved in such Sale Proposal and the terms thereof. Each such Shareholder, upon receipt of a
Required Sale Notice, shall be obligated, which obligation shall be enforceable by any Shareholder voting in favor thereof (or their designee), to sell their shares and participate in the transaction (a “Required
Sale”) contemplated by the Sale Proposal, vote their Shares in favor of such Sale Proposal at any meeting of shareholders called to vote on or approve such Sale Proposal and otherwise to take all necessary action to cause the
Company and its shareholders to consummate such Required Sale. Any such Required Sale Notice may be rescinded by such Shareholders by delivering written notice thereof to all of the other Shareholders of the Company. 
 Section 6. Pre-emptive Rights 
 Each
Shareholder has the right of first offer to purchase such Shareholder’s Pro Rata Share, of all (or any part) of any “New Securities” (as defined in Section 6.A) that the Company may from time to time issue after the date
of adoption of the Charter. For purpose of this Section 6, a Shareholder’s Pro Rata Share in respect of a proposed issuance of New Securities shall mean such Shareholder’s Pro Rata Share immediately before such proposed
issuance of New Securities. 
 A. “New Securities” shall mean any Ordinary Shares or Preferred Shares, whether
now authorized or not, and rights, options or warrants to purchase such Ordinary Shares or Preferred Shares, and securities of any type whatsoever that are, or may become, convertible or exchangeable into such Ordinary Shares or Preferred Shares;
provided, however, that the term “New Securities” does not include: 
 (i) any Ordinary Shares issued
or issuable upon conversion of the Series C Preferred Shares, Series B Preferred Shares or Series A Preferred Shares; 
 (ii)
up to 8,446,518 Ordinary Shares (or options, warrants or rights therefor) granted or issued hereafter to employees, officers, directors or consultants to, the Company or any subsidiary of the Company pursuant to a bona fide employment related share
purchase or option plan (a “ESOP Plan”) approved by the Board and as may be approved from time to time by the Investors pursuant to Section 11; 
 (iii) any Ordinary Shares issued in connection with a bona fide at-arm’s-length acquisition of another corporation or entity by the
Company by consolidation, merger, purchase of all or substantially all of the assets, or other reorganization in which the Company acquires, in a single transaction or series of 

  

 12 

 
related transactions, all or substantially all of the assets of such other corporation or entity or fifty percent (50%) or more of the voting power of
such other corporation or entity or fifty percent (50%) or more of the equity ownership of such other entity which acquisition has been approved by the Investors pursuant to Section 11; 
 (iv) any Ordinary Shares or Preferred Shares issued without consideration in connection with any share split or share dividend or other
similar event in which all shareholders of the Company are entitled to participate ratably; 
 (v) any Ordinary Shares or
Preferred Shares that may otherwise deemed to be issued upon adjustment of a Conversion Price pursuant to Article 8(e) of the Charter; and 
 (vi) any Ordinary Shares issued by the Company pursuant to an underwritten public offering which has been approved by Investors pursuant to Section 11. 
 B. If the Company proposes to undertake an issuance of New Securities, it shall give to each Shareholder written notice of its intention to issue
New Securities (the “Notice”), describing the type of New Securities and the price and the general terms upon which the Company proposes to issue such New Securities. Each Shareholder shall have forty-five (45) days from
the date of mailing of any such Notice to agree in writing to purchase such Shareholder’s Pro Rata Share of such New Securities for the price and upon the general terms specified in the Notice by giving written notice to the Company and stating
therein the quantity of New Securities to be purchased (not to exceed such Shareholder’s Pro Rata Share. If any Shareholder fails to so agree in writing within such forty-five (45) day period to purchase such Shareholder’s Pro
Rata Share of an offering of New Securities (a “Nonpurchasing Holder”), then such Nonpurchasing Holder shall forfeit the right hereunder to purchase that part of its Pro Rata Share of such New Securities that it did not so
agree to purchase. Each Shareholder shall have a right of over-allotment such that if any other Shareholder fails to exercise its right hereunder to purchase its entire Pro Rata Share of New Securities, the other Shareholders may purchase the
balance of the Nonpurchasing Holder’s portion on a pro rata basis (with a further right of over-allotment for any portion of such unsubscribed New Securities that remains unsubscribed) within forty-five (45) days from the date such
Nonpurchasing Holder fails to exercise its right hereunder to purchase its entire Pro Rata Share of New Securities. 
 C. If the
Shareholders fail to exercise in full the right of first offer within the 90-day period provided for in Section 6.B, then the Company shall have 90 days after the expiration of such 90-day period to sell the New Securities with respect
to which the Shareholders’ rights of first offer hereunder were not exercised, at a price and upon general terms not materially more favorable to the purchasers thereof than specified in the Company’s Notice to the Shareholders. In the
event that the Company has not issued and sold the New Securities within such 90-day period, then the Company shall not thereafter issue or sell any New Securities without again first offering such New Securities to the Shareholders pursuant to this
Section 6. 
  

 13 

 Section 7. Information Rights. 
 A. Information and Inspection Rights. The Company shall provide to each Investor and agrees that for so long as such Investor holds Shares,
the Company shall: 
 (i) Monthly Reports. Furnish to such Investor within fifteen (15) days after the end of each
such month, a monthly financial report summarizing the material financial and operating data of the Company Group for the applicable period (including capital expenditure during that period and sales successfully closed during that period) and
containing an updated sales forecast, monthly balance sheets, income statements and cash flow statements of the Company Group; 
 (ii) Quarterly Reports. Furnish to such Investor within forty-five (45) days after the end of each fiscal quarter of the Company, unaudited consolidated quarterly financial statements for such fiscal quarter, including a balance
sheet as of the end of such fiscal quarter, a statement of income and a statement of cash flows of the Company Group for such fiscal quarter, setting forth in each case in comparative form the figures from the Company’s previous fiscal year (if
any) and for the three, six or nine months then ended, as the case may be; 
 (iii) Annual Reports. Furnish to
such Investor within ninety (90) days after the end of each fiscal year of the Company, consolidated annual financial statements for such fiscal year, including a balance sheet as of the end of such fiscal year, a statement of income and a
statement of cash flows of the Company Group for such year, in each case, audited by a “big-four” international accounting firm and setting forth in comparative form the figures from the Company Group’s previous fiscal year, if any;
and 
 (iv) Annual Budget. Furnish to such Investor no later than thirty (30) days prior to the end of the fiscal
year an operating budget for the Company for the next fiscal year; 
 (v) Investment Documents. Promptly upon written
request from the Investor, current versions of this Agreement and other related investment documents and all documents relating to any subsequent financings by the Company or otherwise affecting the Preferred Shares or shares issued upon conversion
of the Preferred Shares, bearing the signatures of all parties, and of the Charter bearing the file stamp of the appropriate government authority, in each case with all amendments and restatements thereto; the copies of the documents to be provided
under this Section 7 may be delivered in either hardcopy or in Adobe Portable Document Format (PDF); and 
 (vi)
Other Information. Promptly furnish to such Investor copies of all financial statements made available to the Company’s Board of Directors and such additional financial and other information as such Investor may from time to time
reasonably request. 
  

 14 

 (a) All financial statements to be provided to the Investors pursuant to this Section 7 and
pursuant to any other Transaction Agreement, including the Charter, shall be prepared in the English language in accordance with IFRS, and shall consolidate all of the consolidated financial results of OpCo. 
 B. Inspection Rights. The Company covenants and agrees that, commencing on the date of this Agreement, and for so long as any Investor
holds not less than one percent (1%) of the Company’s Ordinary Share Equivalents, the Investor or its appointee shall have the right of inspection during normal business hours, including the right to access, examine and copy all books or
accounts of any member of Company Group, and to discuss the business, operations and conditions of the Company Group with their respective directors, officers, employees, accounts, legal counsel and investment bankers, such right to be exercised
reasonably by taking into consideration the Company’s confidential and proprietary information, legal privilege (or analogous legal doctrines). 
 C. Termination of Rights. Except as set forth in Section 7.D below, the foregoing information and inspection rights shall terminate upon the closing of the Qualified Public Offering.

 D. Information Rights After a Qualified Public Offering. The Company covenants and agrees that, for so long as any Investor
holds not less than one per cent. of the Company’s Ordinary Share Equivalents, the Company will deliver to such Investor (i) promptly after filing, copies of all of the Company’s annual and periodic reports made available to its
shareholders as well as all public reports (including any periodic, interim, or extraordinary reports) filed with the Securities and Futures Commission of the Hong Kong Special Administrative Region, the China Securities and Regulatory Commission of
the People’s Republic of China, the U.S. Securities and Exchange Commission, or any other stock exchange or securities regulatory authority, and (ii) promptly upon request, copies of current versions of investment document and all
documents relating to any subsequent financings by the Company, or otherwise affecting the Shares or the holders of the Shares, in each case with all amendments and restatements. This Section 7.D shall survive termination of this
Agreement. 
 Section 8. Directors and Management. 
 A. If a majority of the Board so requires, the Company shall: 
 (i) purchase and, at
all times, maintain for the benefit of each Investor Director and his alternate, insurance against liability for negligence (including gross negligence), default (including willful default), breach of duty and breach of trust for an insured amount
of not less than US$5,000,000; and 
 (ii) deliver to each Investor Director a copy of the policy documents in relation to
such insurance. 
  

 15 

 B. Election of the Board of Directors. At each annual meeting of the Shareholders of the
Company, or at any meeting of the Shareholders at which members of the Board are to be elected, or whenever members of the Board are to be elected by written consent, the Company hereby agrees to take such actions as are necessary, and each
Shareholder shall take, from time to time, all action (including, without limitation, voting the Shares whether now owned or hereinafter acquired, over which he, she or it exercises voting control, calling special meetings of Shareholders to amend
the Charter and executing and delivering written consents) necessary to fix the number of members of the Board of the Company at five (5) members (not including alternate directors as follows: 
 (i) The holders of Series C Preferred Shares, voting together as a single class, shall be entitled to appoint, and remove from such
appointment, one (1) director (the “Series C Director”) to the Board and each committee thereof and to the OpCo Board, and the board of directors of each Subsidiary, provided that so long as any holder of Series C
Preferred Shares, together with its Affiliates, holds a greater number of Series C Preferred Shares than any other holder of Series C Preferred Shares, such holder shall have the right to appoint the Series C Director to be appointed by the holders
of Series C Preferred Shares. 
 (ii) The holders of Series B Preferred Shares, voting together as a single class, shall be
entitled to appoint, and remove from such appointment, two (2) directors (the “Series B Directors”) to the Board and each committee thereof and to the OpCo Board, and the board of directors of each Subsidiary; provided
that for so long as TDF and Redpoint respectively hold at least fifty percent (50%) of the Series B Preferred Shares held by them as at December 1, 2006, each of them shall be entitled exclusively to appoint one Series B Director on behalf
of the holders of Series B Preferred Shares. 
 (iii) The holders of Series A Preferred Shares, voting unanimously as a single
class, shall be entitled to appoint, and remove from such appointment, one (1) director (the “Series A Director”) to the Board and each committee thereof and to the OpCo Board, and the board of directors of each
Subsidiary; provided that the Series A Director initially nominated by the holders of Series A Preferred Shares shall be the Chief Executive Officer of the Company. 
 (iv) The holders of Ordinary Shares, voting together as a single class, shall be entitled to appoint, and remove from such appointment,
one (1) director to the Board of the Company and each committee thereof and to the OpCo Board, and the board of directors of each Subsidiary; provided that should the Series A Director at any time not be a member of the senior management of the
Company (as determined by a majority of the Board), the number of the members of the Board shall be increased to six (6), and the holders of Ordinary Shares, voting together as a single class, shall be entitled to appoint, and remove from such
appointment, one (1) additional director to the Board of the Company and each committee thereof and to the OpCo Board, and the board of directors of each Subsidiary. 
  

 16 

 C. Vacancy. In the event of the resignation, death, removal or disqualification of a
Director selected by any party or parties as provided in Section 8.A, such party or parties, as the case may be, shall promptly nominate a new Director, and, after written notice of the nomination has been given by such party or parties,
as the case may be, to the other parties, the Company shall take such actions as are necessary and each Shareholder shall vote any Shares of the Company, whether now owned or hereafter acquired, over which he, she or it exercises voting control, to
elect such nominee to the Board as set forth herein. 
 D. Removal. Any Director selected by any party or parties as provided
herein may be removed from the Board at any time and from time to time, with or without cause (subject to the Charter as in effect from time to time and any requirements of law), in the sole discretion of such party or parties, as the case may be,
and after written notice by such party or parties, as the case may be, to each of the parties hereto of the new nominee to replace such Director, the Company shall take such actions as are necessary and each Shareholder shall promptly vote any
Shares of the Company, whether now owned or hereafter acquired, over which he, she or it exercises voting control, to elect such nominee to the Board. 
 E. Boards and committees of subsidiaries. It is agreed that the composition of the board of directors of any subsidiary of the Company will be the same as that of the Company. 
 F. Meetings. The Board shall hold a Board meeting (whether in person or via conference) not less frequently than every two months to
discharge the directors’ duty to review the Company’s progress and results. 
 G. Board Observers. Each Investor, for
so long as he, she or it holds any Preferred Shares or any shares resulting from the conversion thereof shall be entitled to nominate a non-voting observer to the Board of the Company and each of its subsidiaries and such observers shall be entitled
to receive notice of and attend all board meetings as though they were a member of the Board but not be entitled to vote on any matter. 
 H. Approval of Quarterly Capital Expenditure Plan. In advance of each fiscal quarter of the Company Group, the Board of the Company shall review and if deemed fit shall approve a quarterly capital expenditure plan of the
Company Group with respect to that quarter, provided that any such approval shall include the affirmative votes of the Preferred Supermajority and the Series C Director. The Company Group shall observe and abide by any such capital
expenditure plan approved by the Board, and the Founders shall take no action (or omit to take action) to cause the Company Group and each Member of Company Group to not so observe and abide. 
 I. Indemnification. The Company and each Subsidiary shall, jointly and severally, indemnify and hold harmless each Investor Director and
his alternate, to the fullest extent permissible by law, from and against all liabilities, damages, actions, suits, proceedings, claims, costs, charges and expenses suffered or incurred by or brought or made against such Investor Director or his
alternate, unless such claims arise from or in 

  

 17 

 
connection with any facts which have been disclosed or otherwise made known to the Investor who appointed such Investor Director or his alternate prior to
the date of this Agreement, as a result of any act, matter or thing done or omitted to be done by him in good faith in the course of acting as a Director or alternate Director, as applicable, of the Company or the Subsidiary, by delivering to such
Investor Director or its alternate, at the time of its appointment as a Director or an alternate Director, an indemnification agreement duly executed by the Company. 
 J. Director Expenses. The Company shall reimburse Investor Directors and Investor Observers for all reasonable out-of-pocket expenses incurred in connection with Board duties and meetings, up to
US$20,000 per calendar year per Investor Director or Investor Observer. 
 K. Waiver. The Company acknowledges that each
Investor will likely have, from time to time, information that may be of interest to the Company or its Subsidiaries (“Information”) regarding a wide variety of matters including (1) an Investor’s technologies,
plans and services, and plans and strategies relating thereto, (2) current and future investments an Investor has made, may make, may consider or may become aware of with respect to other companies and other technologies, products and services,
including technologies, products and services that may be competitive with those of the Company or any of its Subsidiaries, and (3) developments with respect to the technologies, products and services, and plans and strategies relating thereto,
of other companies, including companies that may be competitive with the Company or any of its Subsidiaries. The Company recognizes that a portion of such Information may be of interest to the Company or any of its Subsidiaries. Such Information may
or may not be known by the Investor Directors or Investor Observer. The Company, as a material part of the consideration for this Agreement, agrees that neither any Investor Director nor any Investor Observer shall have any duty to disclose any
Information to the Company or any of its Subsidiaries, or permit the Company or any of its Subsidiaries to participate in any projects or investments based on any Information, or otherwise to take advantage of any opportunity that may be of interest
to the Company or any of its Subsidiaries if it were aware of such Information, and hereby waives, to the extent permitted by law, any claim based on the corporate opportunity doctrine or otherwise that could limit any Investor’s ability to
pursue opportunities based on such Information or that would require any Investor, any representative, any Investor Director or the Investor Observer to disclose any such Information to the Company or any of its Subsidiaries or offer any opportunity
relating thereto to the Company, any of its Subsidiaries, or OpCo. 
 (b) Each Shareholder shall vote all of his or its Shares and shall take
all other necessary or desirable actions within his or its control (whether in such Shareholder’s capacity as a shareholder of the Company or otherwise, and including, without limitation, attendance at meetings in person or by proxy for
purposes of obtaining a quorum and execution of written consents in lieu of meetings), and the Company shall take all necessary and desirable actions within its control (including, without limitation, calling special Board and shareholder meetings),
to give effect to the terms set out in this Agreement. 
  

 18 

 Section 9. Legend on Share Certificates. 
 Each certificate representing Shares shall bear a legend containing the following words (in addition to any other legend required by law or applicable
agreement): 
 “THE SALE, TRANSFER, ASSIGNMENT, PLEDGE OR ENCUMBRANCE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO
THE TERMS AND CONDITIONS OF A SHAREHOLDERS’ AGREEMENT DATED AS OF DECEMBER 7, 2006, AMONG CGEN DIGITAL MEDIA COMPANY LIMITED AND CERTAIN HOLDERS OF THE OUTSTANDING SHARE CAPITAL OF SUCH COMPANY. COPIES OF SUCH AGREEMENT MAY BE OBTAINED AT NO
COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF SUCH COMPANY.” 
 Section 10. Additional
Shares. 
 In the event additional Shares are issued by the Company to a Shareholder or any employee of the Company at any time during
the term of this Agreement, either directly or upon the exercise or exchange of securities of the Company exercisable for or exchangeable into Shares, the Company shall cause such additional Shares, as a condition to such issuance, to become subject
to the terms and provisions of this Agreement. 
 Section 11. Covenants. 
 A. Matters Requiring Investor and Series C Director Consent. In addition to any other rights provided by law and the provisions of the
Charter, each Member of Company Group and each Ordinary Shareholder jointly and severally agrees and undertakes to procure that any action (whether by amendment of the charter or any constitutional documents of any Member of the Company Group, or
otherwise, and whether in a single transaction or a series of related transactions) that effects or approves any of the following transactions with respect to the Company or any Member of the Company Group (the “Tier 1 Reserved
Matters”) shall require the approvals of the Preferred Supermajority and, for so long as holders of Series C Preferred Shares hold in aggregate not less than fifty percent (50%) of the Series C Preferred Shares subscribed by them
on December 7, 2006, the Series C Director: 
 (i) Effect or permit any sale, lease, assignment, transfer, license,
encumbrance, disposition or other conveyance of or security over any material assets of any Member of the Company Group outside the ordinary course of business; 
 (ii) Effect any consolidation or merger of any Member of the Company Group with or into any other corporation; 
  

 19 

 (iii) Acquire or dispose of any material assets outside the ordinary course of business
or any shares or debt or equity securities of any corporation or other entity or acquire any other business as a going concern, by one transaction or a series of transactions, or form any partnership or joint venture with any other person (which
shall not be deemed to include cross-marketing arrangements in which the parties thereto would not be held liable to any other Person for the obligations of each other); 
 (iv) Redeem, purchase or otherwise acquire (or pay into or set aside for a sinking fund for such purpose) any shares, securities or debt
of any Member of Company Group; PROVIDED, HOWEVER, that this restriction shall not apply to the repurchase of Ordinary Shares from employees, officers, directors, consultants or other persons pursuant to an ESOP Plan; 
 (v) Pay or declare any dividend on any shares of or other equity interest in any Member of the Company Group; 
 (vi) Voluntarily effect any change of Chairman, Chief Executive Officer, Chief Financial Officer or Legal Representative (or management
employees with similar responsibilities) of any Member of the Company Group; 
 (vii) Incur any indebtedness that, when
combined with all other then outstanding indebtedness of the any Member of the Company Group exceeds RMB2,000,000 (or its equivalent) in aggregate principal amount outside the budget approved under this Section 11.A; 
 (viii) Make any change in accounting methods, practices, principles, policies and procedures, or change to inconsistent classifications,
judgments and valuation or estimation methodologies, or appoint, remove or change the auditor for any Member of the Company Group; 
 (ix) Make any capital expenditure in aggregate in excess of RMB2,000,000 outside the budget approved under this Section 11.A; 
 (x) Increase, reduce or cancel the authorized or issued share or equity capital of the Company, or issue or sell, or obligate itself to issue or sell, or permit the issuance or sale, of any share capital or debt
securities of the Company, provided, however, that this restriction shall not apply to the issuance of Ordinary Shares, or securities convertible into or exchangeable for Ordinary Shares, to employees, officers, directors, consultants
or other persons pursuant to an ESOP Plan approved under this Section or re-designation of Ordinary Shares as Series C Preferred Shares pursuant to Article 8(e)(ii) of the Charter. 
 (xi) Approve any annual business plan (or any amendment to such business plan) and budget of the Company, and quarterly updates thereof;

 (xii) Approve or authorize the commencement of any business other than as set forth in a business plan approved under this
Section 11.A; 
  

 20 

 (xiii) Take any action to wind up or dissolve any Member of Company Group or undertake
any merger, reconstruction or liquidation of any Member of Company Group or apply for the appointment of a receiver, manager or judicial manager or similar officer in respect of any Member of Company Group; 
 (xiv) Settle, compromise or concede any litigation, legal proceedings, arbitration, mediation or any other dispute resolution procedures
involving any Member of Company Group; 
 (xv) Amend the Charter or any equivalent constitutional documents of any Member of
Company Group in any manner; 
 (xvi) Effect a Company Sale; 
 (xvii) Approve terms of a public offering of Ordinary Shares of the Company (or securities representing such Ordinary Shares), or shares
of any other Member of the Company Group, registered under the Securities Act, or in a similar public offering of Ordinary Shares in a jurisdiction and on a securities exchange or inter-dealer quotation system outside of the United States, including
The Stock Exchange of Hong Kong Limited; or 
 (xviii) Dispose of or dilute the Company’s interest, directly or
indirectly, in any of its Subsidiaries. 
 B. Matters Requiring Investor Consent. In addition to any other rights provided by
law and the provisions of the Charter and without prejudice to any requirement to obtain the consent of the Series C Director under Section 11.A, each Member of Company Group and each Ordinary Shareholder jointly and severally agrees and
undertakes to procure that any action (whether by amendment of the charter or any constitutional documents of any Member of the Company Group, or otherwise, and whether in a single transaction or a series of related transactions) that effects or
approves any of the following transactions with respect to the Company or any Member of the Company Group (the “Tier 2 Reserved Matters”) shall require the approval of the Preferred Supermajority. 
 (i) Increase, reduce or cancel the authorized or issued share or equity capital of any Member of Company Group (other than the Company),
or issue or sell, or obligate itself to issue or sell, or permit the issuance or sale, of any share capital or debt securities of any Member of Company Group (other than the Company), PROVIDED, HOWEVER, that this restriction shall not apply to the
issuance of Ordinary Shares, or securities convertible into or exchangeable for Ordinary Shares, to employees, officers, directors, consultants or other persons pursuant to a share incentive or similar scheme approved under this Section or
re-designation of Ordinary Shares as Series C Preferred Shares pursuant to Article 8(e)(ii) of the Charter; 
 (ii)
Approve any transfer of shares or interests in any Member of Company Group other than the Company; 
  

 21 

 (iii) Approve or change the terms of employment (including any material change to
compensation) of any Senior Manager of any Member of the Company Group; 
 (iv) Enter into any transaction with an Affiliate
or modify the terms of any such transaction; approve or make adjustments or modifications to terms of transactions involving the interest of any director or shareholder of any Member of the Company Group, including the making of any loans or
advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director or shareholder of any Member of the Company Group; 
 (v) Adopt, settle or alter the terms of any ESOP Plan or other bonus or profit sharing scheme; or 
 (vi) Dispose of or dilute the Company’s interest, directly or indirectly, in any of its Subsidiaries. 
 C. Protection of Reserved Matters. Each Member of the Company Group and each Ordinary Shareholder hereto jointly and severally undertakes
to each Investor that it shall exercise all its rights and powers in relation to the Company Group so as to procure that, subject to applicable law, (i) no resolutions to approve, authorize and ratify any of the Tier 1 Reserved Matters shall be
considered or passed or effected at any meeting of shareholders or otherwise, without first obtaining consent of the Preferred Supermajority and, for so long as holders of Series C Preferred Shares hold in aggregate not less than half of the Series
C Preferred Shares subscribed by them on December 7, 2006, the Series C Director, and (ii) no resolutions to approve, authorize and ratify any of the Tier 2 Reserved Matters shall be considered or passed or effected at any meeting of
shareholders or otherwise, without first obtaining consent of the Preferred Supermajority. 
 D. Initial Public Offering. Each
of the Founders and the Company shall use all reasonable commercial effort to complete a Qualified Public Offering on or prior to the second anniversary of the date hereof. The Founders and the Company agree that each Investor has the right to sell
up to thirty percent (30%) of the Series C Conversion Shares it may then hold on a secondary basis pursuant to the Company’s initial public offering. To the extent that the managing underwriter in such initial public offering advising the
Company that additional sale of Ordinary Shares held by the Investors would not materially interfere with the successful marketing of the Company’s securities in such initial public offering, then each Investor may sell up to thirty percent
(30%) of all the Ordinary Shares it may then hold, as determined to be appropriate by the managing underwriter. 
 E.
Non-Competition. Each Founder undertakes to each of the Investors that for a period of eighteen (18) months after he ceases to be employed by a Member of the Company Group, he will not, without the prior written consent of the Investors:

  

 22 

 (i) either on his own account or through any of his Affiliates, or in conjunction with or
on behalf of any other Person, carry on or be engaged, concerned or interested directly or indirectly whether as shareholder, director, employee, partner, agent or otherwise carry on any business in direct competition with the primary business then
operated by the Company in PRC; 
 (ii) either on his own account or through any of his Affiliates or in conjunction with or
on behalf of any other Person solicit or entice away or attempt to solicit or entice away from any Member of the Company Group, the business of any person, firm, company or organization who is or shall at any time within twelve (12) months
prior to such cessation have been a customer, client, representative, agent or correspondent of such Member of the Company Group or in the habit of dealing with such Member of the Company Group; 
 (iii) either on his own account or through any of his Affiliates or in conjunction with or on behalf of any other Person, employ, solicit
or entice away or attempt to employ, solicit or entice away from any Member of the Company Group any person who is or shall have been at the date of or within 12 months prior to such cessation an officer, manager, consultant or employee of any such
Member of the Company Group whether or not such person would commit a breach of contract by reason of leaving such employment (other than pursuant to advertisements of general circulation); 
 (iv) neither he nor any of his Affiliates will at any time hereafter, in relation to any trade, business or company use in contravention
of law any business or trade name or any permutation, combination, derivation or part thereof now or hereafter used by any Member of the Company Group in its name or in the name of any of its products, services or their derivative terms, or the
Chinese or English equivalent or any similar word in such a way as is likely to be confused with the name of any Member of the Company Group or the product or services or any other products or services of any Member of the Company Group, and shall
use all reasonable endeavors to procure that no such name shall be used by any of his Affiliates; 
 (v) Each and every
obligation under clause (a) of this Section 11.E shall be treated as a separate obligation and shall be severally enforceable as such and in the event of any obligation or obligations being or becoming unenforceable in whole or in
part, such part or parts which are unenforceable shall be deleted from such Section and any such deletion shall not affect the enforceability of the remainder parts of such Section; 
 (vi) If any restrictions in this Section 11.E shall be adjudged to be invalid or unenforceable as being in excess of what is
reasonably required for the protection of the Company Group or the Shareholders, but would be valid if parts of this Section 11.E were deleted or the scope herein reduced, all restrictions in this Section 11.E shall apply
with such modifications as may be necessary to make them legally valid and effective; 
  

 23 

 (vii) Each Founder hereby covenants that he shall continue to devote 100 per cent.
of his working time to managing the business and operations of the Company Group; and 
 (viii) The provisions of this
Section 11.E shall survive termination of this Agreement. 
 F. Duration of Agreement. The rights and obligations
of each Shareholder under this Agreement, save for any rights or obligations that by their express terms survive termination of this Agreement, shall terminate as to such Shareholder upon the earliest to occur of (a) the Transfer of all Shares
owned by such Shareholder and (b) a Qualified Public Offering. 
 G. Appointment of Certain Officers. The Investors
may nominate Senior Managers, and other key management personnel and key technical personnel of the Company Group, for appointment by the Board in its discretion or the boards of directors of other members of the Company Group, as the case may be.

 H. Establishment of Compensation Committee. The Board shall forthwith establish a Compensation Committee consisting of one
(1) Series C Director, one (1) Series B Director and the Chairman of the Board of the Company nominated by Ordinary Shareholders representing a majority of the Shares held by the Ordinary Shareholders. The Compensation Committee shall
propose the terms of the Company’s share incentive plan and all grants of awards thereunder to the Board, for approval and adoption by the Board and the Shareholders, shall have the power and authority to administer the Company’s share
incentive plan and to grant options thereunder in accordance with such approval by the Board and the Shareholders, and shall have such other powers and authorities as the Board shall delegate to it. 
 I. Non-Disposal. Without prejudice to any other provisions in this Agreement, each Ordinary Shareholder irrevocably and unconditionally
undertakes to the Investors that without the prior written approval of the Preferred Supermajority and the Series C Director, he (regardless of its employment status with the Company Group) or it shall not, directly or indirectly, grant any pledge,
mortgage, lien, encumbrance or security interest over the Ordinary Shares registered in his or her name (other than as contemplated in this Agreement or the Charter). 
 J. Lock-up. Each Ordinary Shareholder acknowledges and agrees that he it shall not sell, make any short sale of, loan, grant any option for the purchase of, pledge, charge or otherwise transfer or
dispose of any Shares or other securities of the listing entity without the prior written consent of the underwriter for such period of time (not to exceed 180 days) following the effective date of an initial public offering. The Company agrees that
it shall not and it shall procure that the listing entity shall not, release any of the Ordinary Shareholders, an officer of the listing entity, Founder, director from such lock-up. 
  

 24 

 K. ESOP. If the Final Post-Money Valuation is determined to be at least US$60,674,264, the
Company shall reserve 2.4% of its then fully-diluted share capital as additional Ordinary Shares (or options, warrants or rights therefor) to be granted or issued to employees, officers, directors or consultants to, the Company or any subsidiary of
the Company pursuant to an ESOP Plan approved pursuant to Section 11; provided that the issue price of such Ordinary Shares shall not be lower than the then effective conversion price for Series C Preferred Shares as calculated in
accordance with the Charter. 
 L. Non-Group Company. Each Founder hereby irrevocably and unconditionally undertakes that he or
she shall cause any Person (other than a natural person or a Member of the Company Group) controlled by him or her (separately or together with any other Founder) not to (i) compete in any way with any Member of the Group Company; (ii) use
the phrase “CGEN” or “

” in its name, brand or marketing material; and (iii) hold itself out as a Member of the Company Group. 
 M. Company’s Option. Each Founder hereby irrevocably and unconditionally grants to the Company an option to purchase or designate any other Person to purchase all or part of his or her ownership interest in OpCo, or any
other Person (other than a natural person) organized under the laws of the PRC that is engaged in business in competition with the business of any member of the Company at any time from the date hereof to the seventh anniversary of the date hereof
for a consideration that is the lower of (x) US$1,000 or (y) minimum consideration as may be required for such purchase to be valid and enforceable under the laws of the PRC. The Company may exercise this option more than once. Upon the
Company’s exercise of such option, the Founders and the Ordinary Shareholders shall be obligated to sell to the Company or the Person designated by the Company such ownership interest as the Company may elect to purchase. Each of the Company,
the Founders and the Ordinary Shareholders hereby agree with the Investors that the Preferred Supermajority may enforce this Section 11.M on behalf of the Company. 
 N. SAFE Registration. Each Founder and any other Shareholder deemed to be a PRC resident for purposes of the relevant PRC foreign exchange
rules undertakes to make best efforts to complete all approval and/or registration procedures, as required by any PRC governmental authorities, including without limitation the PRC State Administration of Foreign Exchange and/or its local branches,
with regard to such Founder’s or Shareholder’s equity interest (beneficial or legal and direct or indirect) in the Company as soon as is practicable. 
 O. Compliance with Laws. Each Member of the Company Group shall, and the Founders shall cause each Member of the Company Group to comply with all applicable laws and regulations (including without
limitation any laws, regulation, notices, decrees and decisions in the jurisdiction of its organization or where it conducts business concerning bribery, corruption and anti-money laundering matters.) 
 P. FCPA. Each of the Founders and Members of the Company Group represents and warrants that he or it is aware of and familiar with the
provisions of the U.S. Foreign Corrupt Practices Act of 1977, as amended (“FCPA”) and its purpose, and further undertakes that he or it will not take any action or make any payment (including promises to take action or to
make payment) in violation of, or that might cause any Investor or its Affiliates or subsidiary in violation of, the FCPA. 
  

 25 

 Q. Performance Ratchet. If there is an ratchet adjustment in respect of the Series C
Preferred Shares under Article 8(e)(ii) of the Charter, each Ordinary Shareholders (other than Totnes International Limited) shall transfer such number of Ordinary Shares to the Investors holding Series C Preferred Shares in accordance with
Article 8(e)(ii) of the Charter for an aggregate consideration of US$1.00. Pursuant to Article 8(e)(ii) of the Charter, the Company shall re-designate such transferred Ordinary Shares as Series C Preferred Shares ranking pari
passu with all other Series C Preferred Shares. To the extent that any shareholders’ approval is necessary, each Shareholder shall vote its Shares to approve such transfer and re-designation. 
 Section 12. Severability; Governing Law; Dispute Resolution. 
 A. Severability. If any provision of this Agreement shall be determined to be illegal and unenforceable by any court of law, the remaining provisions shall be severable and enforceable in accordance with
their terms. 
 B. Governing Law. The execution, effectiveness, construction, performance, amendment and termination of this
Agreement shall be governed by the substantive law of the State of New York (without regard to principles of conflict of laws). 
 C.
Dispute Resolution. 
 (i) Any dispute, controversy or claim (each, a “Dispute”) arising out of
or relating to this Agreement shall be resolved first through consultation. Such consultation shall begin immediately after one party hereto has delivered to the other party hereto a written request for such consultation. If within 30 days following
the date on which such notice is given, the Dispute cannot be resolved through consultation, such Dispute shall be submitted to arbitration upon the request of any party to the Dispute with notice to each other party to the Dispute (the
“Arbitration Notice”). 
 (ii) The arbitration shall be conducted in Hong Kong under the auspices of
the Hong Kong International Arbitration Centre (“Centre”). There shall be three (3) arbitrators. Each party to the Dispute shall choose one (1) arbitrator. The Secretary General of the Centre shall select the third
arbitrator, who shall be qualified to practice law in Hong Kong. If any of the members of the arbitral tribunal have not been appointed within thirty (30) days after the Arbitration Notice is given, the relevant appointment shall be made by the
Secretary General of the Centre. 
 (iii) The arbitration proceedings shall be conducted in English. The arbitration tribunal
shall apply the Arbitration Rules of the United Nations Commission on International Trade Law, as in effect at the time of the arbitration. However, if such rules are in conflict with the provisions of this Section 12.C, including the
provisions concerning the appointment of arbitrator, the provisions of this Section 12.C shall prevail. 
  

 26 

 (iv) Each party to the arbitration shall cooperate with each other party to the
arbitration in making full disclosure of and providing complete access to all information and documents requested by such other party in connection with such arbitration proceedings, subject only to any confidentiality obligations binding on such
party. 
 (v) The award of the arbitration tribunal shall be final and binding upon the parties, and the prevailing party may
apply to a court of competent jurisdiction for enforcement of such award. 
 (vi) The arbitrators shall decide any Dispute
submitted by the parties to the arbitration strictly in accordance with the substantive law of the State of New York and shall not apply any other substantive law. 
 (vii) Any party to the Dispute shall be entitled to seek preliminary injunctive relief, if possible, from any court of competent
jurisdiction pending the constitution of the arbitral tribunal. 
 (viii) During the course of the arbitration tribunal’s
adjudication of the Dispute, this Agreement shall continue to be performed except with respect to the part in dispute and under adjudication. 
 Section
13. Successors and Assigns. 
 This Agreement shall bind and inure to the benefit of the parties and their respective successors
and assigns, transferees, legal representatives and heirs. 
 Section 14. Notices. 
 All notices, requests, consents and other communications hereunder to any party shall be deemed to be sufficient if contained in a written instrument
delivered in person (with written confirmation of receipt) or by telecopy (with written confirmation of transmission) or sent by nationally-recognized overnight courier (with written confirmation of receipt) or first class registered or certified
mail, return receipt requested, postage prepaid, addressed to such party at the address set forth below or at such other address as may hereafter be designated in writing by such party to the other parties: 
 if to the Company, to: 
 CGEN Digital Media
Company Limited 
 Suite 3293-94, Tower B, City Center of Shanghai 
 No. 100 Zunyi Rd. 
 Shanghai 200051, P.R.
China 
 Telephone: +86 21 6237 2200 
 Telecopy: +86 21 6237 1918 
  

 27 

 Attention: CEO 
 with a copy to: 
 Paul Hastings Janofsky & Walker 
 22/F, Bank of China Tower 
 1 Garden Road
Central Hong Kong 
 Attention: Basil Hwang 
 if to the Shareholders, to their respective addresses set forth on Schedule III hereto with a copy to counsel to such Shareholder indicated thereon. 
 All such notices, requests, consents and other communications shall be deemed to have been delivered (a) in the case of personal delivery or delivery by telecopy,
on the date of such delivery, (b) in the case of dispatch by nationally-recognized overnight courier, on the next business day following such dispatch or three (3) business days after such deposit for international deliveries and
(c) in the case of mailing, on the third business day after the posting thereof. A delivery between the People’s Republic of China and Hong Kong shall be considered an international delivery. 
 Section 15. Modification; Assignment. 
 A. Except as otherwise provided herein, neither this Agreement nor any provisions hereof can be modified, changed, discharged or terminated except by an instrument in writing signed by (a) the Company, (b) Shareholders
holding two-thirds of the then outstanding Series C Preferred Shares and Shareholders holding two-thirds of the then outstanding Series B Preferred Shares, each voting as a separate class, and (c) the holders of a majority of the Ordinary
Shares then held by the Shareholders; provided, however, that no modification or amendment shall be effective to reduce the percentage of the Shares the consent of the holders of which is required under this Section 15 nor
shall any modification or amendment discriminate against any Shareholder without the consent of such Shareholder. 
 B. Adherence
Agreement. For any transfer of Shares to be deemed effective, the transferee shall assume the obligations of the transferor under this Agreement by executing and delivering to the Company an Adherence Agreement substantially in the form attached
hereto as Exhibit A. Upon the execution and delivery of an Adherence Agreement by any transferee, such transferee shall be deemed to be a Ordinary Shareholder or Investor, as appropriate. By their execution hereof, each of the parties hereto
appoints the Company as its attorney-in-fact for the limited purpose of executing any Adherence Agreement which may be required to be delivered pursuant to this Section 15B. 
  

 28 

 Section 16. Headings. 
 The headings of the sections of this Agreement have been inserted for convenience of reference only and shall not be deemed to be a part of this Agreement. 
 Section 17. Nouns and Pronouns. 
 Whenever the
context may require, any pronouns used herein shall include the corresponding masculine, feminine or neuter forms, and the singular form of names and pronouns shall include the plural and vice versa. 
 Section 18. Entire Agreement. 
 This Agreement
and the other writings referred to herein or delivered pursuant hereto contain the entire agreement among the parties hereto with respect to the subject matter hereof and supersede all prior and contemporaneous agreements and understandings with
respect thereto, including, without limitation, the Prior Agreement. 
 Section 19. Confidentiality and Announcements. 
 A. Each Investor acknowledges that the Company could be irreparably damaged if trade secrets concerning the business and affairs of the Company
were disclosed to or utilized on behalf of any person. Each of the Investors covenants and agrees to and with the Company that, except as otherwise provided in this Agreement, it will not, at any time, directly or indirectly, without the prior
written consent of the Company, divulge, and will not authorize any of its partners, shareholders, directors, officers, employees or agents to divulge, to any person any trade secrets if such release is intended for, or may result in, its public
dissemination. The foregoing requirements of confidentiality shall not apply to information: (i) that is now or in the future becomes freely available to the public through no fault of or action by such Investor; (ii) that is in the
possession of such Investor or the using or disclosing party prior to the time such information was obtained from the Company or that is independently acquired by such Investor or the using or disclosing party without the aid, application or use of
such other information; (iii) that is obtained by such Investor or the using or disclosing party in good faith without knowledge of any breach of a secrecy arrangement from a third party; or (iv) that is required to be disclosed by
applicable law or order of government agency or self-regulatory body (including, without limitation, the Hong Kong Stock Exchange). 
 B. Non-Disclosure of Terms. The terms and conditions of this Agreement, the Related Agreements and all exhibits and schedules attached hereto and thereto (collectively, the “Financing Terms”), including
their existence, shall be considered confidential information and shall not be disclosed by any party hereto to any third party except in accordance with the provisions set forth below; provided that such confidential information shall not
include any information that is in the public domain other than by the breach of the confidentiality obligations hereunder. 
 C.
Press Releases, Etc. Any press release issued by any party hereto or any Member of the Company Group shall not disclose any of the Financing Terms and the final form of such press release shall be approved in advance in writing by the
Investors. No other announcement regarding any of the Financing Terms in a press release, conference, advertisement, announcement, professional or trade publication, mass marketing materials or otherwise to the general public may be made without
each Investor’s prior written consent at its sole discretion. 
  

 29 

 D. Permitted Disclosures. Notwithstanding anything in the foregoing to the contrary:

 (i) any parties hereto may disclose any of the Financing Terms to its current or bona fide prospective investors,
directors, officers, employees, shareholders, investment bankers, lenders, accountants, auditors, insurers, business or financial advisors, and attorneys in each case only where such persons or entities are advised of the confidential nature of the
information or under appropriate nondisclosure obligations imposed by professional ethics, law or otherwise; 
 (ii) each
Investor (and its fund manager) may, without disclosing the identities of the other Investors or the Financing Terms of their respective investments in the Company without their or the Company’s consent, disclose such Investor’s investment
in the Company to any other Person or to the public at its sole discretion and in relation thereto may use the Company’s logo and trademark (without requiring the Company’s further consent). If it does so, the other parties shall have the
right to disclose to any other Person any such information disclosed in a press release or other public announcement by such Investor. 
 (iii) notwithstanding clause (d) (i) immediately above, each Investor shall have the right to disclose: 
 (a) any information to such Investor’s and/or its fund manager’s and/or its Affiliate’s legal counsel, fund manager auditor, insurer, accountant, consultant or to an officer, director, general partner,
limited partner, its fund manager, shareholder, investor, bona fide potential investor, counsel or advisor, or employee of such Investor and/or its Affiliate; provided, however, that any such person shall be advised of the confidential
nature of the information or are under appropriate non-disclosure obligation imposed by professional ethics, law or otherwise; 
 (b) any information for fund and inter-fund reporting purposes; 
 (c) any information as required by law, government
authorities, exchanges and/or regulatory bodies; and/or 
 (d) any information to bona fide prospective purchasers/investors
of any share, security or other interests in the Company, 
 (e) any information contained in press releases or public
announcements of the Company pursuant to Section 19C above. 
  

 30 

 (iv) the confidentiality obligations set out in this Section 19 do not apply
to: 
 (a) information which was in the public domain or known to the relevant party before it was furnished to it by another
party hereto otherwise than as a result of (i) a breach by that party of this Section 19 or (ii) a breach of a confidentiality obligation by a third party discloser, where the breach was actually known to that relevant party;

 (b) information the disclosure of which is necessary in order to comply with any applicable law, the order of any court,
the requirements of a stock exchange or to obtain tax or other clearances or consents from any relevant authority; or 
 (c)
information disclosed by any director or observer of the Company to its appointer or any of its Affiliates or to any person to whom disclosure would be permitted in accordance with the foregoing provisions of this Section 19.D .

 E. Legally Compelled Disclosure. In the event that any party is requested or becomes legally compelled (including without
limitation, pursuant to securities laws and regulations) to disclose the existence of this Agreement and exhibits and schedules attached to such agreement, or any of the Financing Terms hereof in contravention of the provisions of this
Section 19, such party (the “Disclosing Party”) shall provide the other parties (the “Non-Disclosing Parties”) with prompt written notice of that fact and use all reasonable efforts to
assist an affected Non-Disclosing Party to seek a protective order, confidential treatment or other appropriate remedy. In such event, the Disclosing Party shall furnish only that portion of the information that is legally required and shall
exercise reasonable efforts to keep confidential such information to the extent reasonably requested by any Non-Disclosing Party. 
 F. Notices. All notices required under this section shall be made pursuant to Section 14 of this Agreement. 
 G. This Section 19 constitutes the entire agreement between the parties as to the matter of confidentiality and supersedes any separate nondisclosure agreements executed by the Company with the Investors (and/or their
Affiliates) with respect to the transactions contemplated herein. This Section 19 shall survive the termination of this Agreement and the other Related Documents. 
 H. Access to Information. Each Member of the Company Group shall allow access to Confidential Information only to directors, officers and
employees of the Company Group whose duties require them to possess such Confidential Information, and shall take all reasonable steps to minimize the risk of disclosure of Confidential Information. 
  

 31 

 I. Other Information. The provisions of this Section shall be in addition to, and not in
substitution for, the provisions of any separate nondisclosure agreement executed by any Founder or Member of the Company Group. 
 J.
Survival. This Section shall survive termination of this Agreement. 
 Section 20. Several Liability of Investors. Each Investor party
hereto shall be severally (and not jointly and severally or jointly with any other Person) liable for its own obligations under this Agreement. 
 Section
21. Investor Rights. Any rights of any Investor under this Agreement may, without prejudice to such Investor to exercise any such rights, be exercised by any fund manager of such Investor or their respective nominees (“Fund
Manager”), unless such Investor has given notice to the other parties to this Agreement that any such rights cannot be exercised by such Fund Manager. 
 Section 22. Counterparts. 
 This Agreement may be executed by facsimile signature and in any number of counterparts,
and each such counterpart hereof shall be deemed to be an original instrument, but all such counterparts together shall constitute but one agreement. 
 [Signature Pages to Follow] 
  

 32 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first
written above. 
  

	
	CGEN DIGITAL MEDIA COMPANY LIMITED
	
	/s/
	By:
	Title:
	
	CGEN MEDIA TECHNOLOGY COMPANY LIMITED
	
	/s/
	By:
	Title:
	
	CGEN DIGITAL TECHNOLOGY (SHANGHAI) CO., LTD.
	([GRAPHIC])
	
	/s/
	By:
	Title:
	
	SHANGHAI CGEN DIGITAL MEDIA NETWORK CO., LTD.
	([GRAPHIC])
	
	/s/
	By:
	Title:

 [SIGNATURE PAGE TO SHAREHOLDERS AGREEMENT] 
  

 33 

	
	
	/s/
	Chan Yi Sing
	(Singapore NRIC No. S1306068A)
	
	/s/
	Tian Guanyong (

)
	(PRC ID No. 133031651224065)
	
	/s/
	Cao Xiaofeng (

)
	(PRC ID No. 310112197008270052)
	
	/s/
	Yao Fang (

)
	(PRC ID No. 310221670521081)
	
	/s/
	Zhu Hai Guang (

)
	(PRC ID No. 410423197106070010)

 [SIGNATURE PAGE TO SHAREHOLDERS AGREEMENT] 
  

 34 

	
	TOTNES INTERNATIONAL LIMITED
	
	/s/
	By:
	Title:

 [SIGNATURE PAGE TO SHAREHOLDERS AGREEMENT] 
  

 35 

			
	S.I. TECHNOLOGY VENTURE CAPITAL LIMITED
	
	/s/
	By:
	Title:

 [SIGNATURE PAGE TO SHAREHOLDERS AGREEMENT] 
  

 36 

			
	 SUMITOMO CORPORATION EQUITY
 ASIA
LIMITED

	
	/s/
	By:
	Title:

 [SIGNATURE PAGE TO SHAREHOLDERS AGREEMENT] 
  

 37 

			
	JAFCO ASIA TECHNOLOGY FUND III
	
	/s/
	By:
	Title:

 [SIGNATURE PAGE TO SHAREHOLDERS AGREEMENT] 
  

 38 

			
	TDF CAPITAL CHINA II, LP
	
	/s/
	By:
	Title:
	
	TDF CAPITAL ADVISORS, LP
	
	/s/
	By:
	Title:

 [SIGNATURE PAGE TO SHAREHOLDERS AGREEMENT] 
  

 39 

			
	HUITUNG INVESTMENTS (BVI) LIMITED
	
	/s/
	By:
	Title:

 [SIGNATURE PAGE TO SHAREHOLDERS AGREEMENT] 
  

 40 

			
	INVESTLINK CONSULTING (CHINA)
LIMITED
	
	/s/
	By:
	Title:

 [SIGNATURE PAGE TO SHAREHOLDERS AGREEMENT] 
  

 41 

			
	REDPOINT VENTURES II, L.P.
	By its General Partner Redpoint Ventures II, LLC
	
	/s/
	By:	 	John L. Walecka
	Title:	 	Managing Director
	
	REDPOINT ASSOCIATES II, LLC, as nominee
	
	/s/
	By:	 	John L. Walecka
	Title:	 	Managing Director

 [SIGNATURE PAGE TO SHAREHOLDERS AGREEMENT] 
  

 42 

			
	CPI BALLPARK INVESTMENTS LTD.
	
	/s/
	By:	 	John L. Walecka
	Title:	 	Managing Director

 [SIGNATURE PAGE TO SHAREHOLDERS AGREEMENT] 
  

 43 

 Schedule I 
  

									
	 Shareholders
	  	Series A
Preferred
Shares	  	Series B
Preferred
Shares	  	Series C
Preferred
Shares	  	Ordinary
Shares
	 Investors
	  		  		  		  	
	 CPI BALLPARK INVESTMENTS LTD.
	  		  		  	73,683,439	  	
		  		  		  	 	  	
	 TDF CAPITAL CHINA II, LP
	  		  	30,386,346	  	16,013,474	  	
		  		  	 	  	 	  	
	 TDF CAPITAL ADVISORS, LP
	  		  	1,305,713	  	688,106	  	
		  		  	 	  	 	  	
	 REDPOINT VENTURES II, L.P.
	  		  	29,226,450	  	16,324,124	  	
		  		  	 	  	 	  	
	 REDPOINT ASSOCIATES II, LLC
	  		  	675,791	  	377,456	  	
		  		  	 	  	 	  	
	 S.I. TECHNOLOGY VENTURE CAPITAL LIMITED
	  	33,977,284	  		  		  	
		  	 	  		  		  	
	 SUMITOMO CORPORATION EQUITY ASIA LIMITED
	  	9,707,795	  	9,315,431	  	2,769,876	  	
		  	 	  	 	  	 	  	
	 JAFCO ASIA TECHNOLOGY FUND III
	  		  	36,219,496	  	5,273,738	  	
		  		  	 	  	 	  	
	 HUITONG INVESTMENTS (BVI) LIMITED
	  		  	18,109,748	  	2,636,869	  	
		  		  	 	  	 	  	
	 INVESTLINK CONSULTING (CHINA) LIMITED
	  		  	2,513,186	  		  	
	 Ordinary Shareholders
	  		  		  		  	
	 CHAN YI SING
	  		  		  		  	89,719,317
		  		  		  		  	 
	 TOTNES INTERNATIONAL LIMITED
	  		  		  		  	2,912,339

  

 44 

 Schedule II 
 LIST OF COMPETITORS 
  

	(A)	Focus Media Holding Limited and subsidiaries 

  

 45 

 Schedule III 
 Notice Schedule 
 S.I. Technology Venture Capital Limited 
 26/F, Harcourt House 
 39 Gloucester Road 
 Wanchai, Hong Kong 
 Tel: +852 2529 5652 
 Fax: +852 2520 0128 
 Attn: Philip P. Zhai, PhD. 
 Sumitomo Corporation Equity Asia Limited 
 Suite 602, 6th Floor 

One International Finance Centre 
 One Harbour View Street 
 Central 
 Hong Kong 
 Tel: +852 2295 0300 
 Fax: +852 2295 0600 
 Attn: Joe Chang 
 JAFCO Asia Technology Fund III 
 c/o JAFCO Investment (Asia Pacific) Ltd. 
 6 Battery Road 
 #42-01 
 Singapore 049909 
 Fax No.: +65 6221-3690 
 Attention: The President 
 with a copy to: 
 JAFCO Investment (Hong Kong) Ltd 
 30/F, Two International Finance Centre 
 8 Finance Street 
 Central, Hong Kong 
 Tel: +852 2536-1960 
 Fax: +852 2536-1979 
 Attention: General Manager 
 TDF Capital China II, LP 
 and TDF Capital Advisors, LP 
 Unit 2505, K. WAH Center 
 1010 Huaihai Zhong Road 
 Shanghai 200031 
 People’s Republic of China 
 Tel. No.: +86 (21) 5467-0500 
 Fax. No.: +86 (21) 5404-7557

 Attention: Ian Goh 
  

 46 

 Huitung Investments (BVI) Limited 
 Room 2211, 
 Shui On Plaza 
 333 Huai Hai Zhong Road,

 Shanghai 200021 
 People’s Republic of China 

Tel. No.: +86 (21) 64275896-15 
 Fax. No.: +86 (21) 63853266

 Attention: David Tso 
 CHAN Yi Sing, 
 Totnes International Limited 
 CGEN Digital Media Company Limited 

CGEN Media Technology Co., Ltd. 
 CGEN Digital Technology (Shanghai) Co.,
Ltd. 
 Shanghai CGEN Digital Media Network Co., Ltd. 
 c/o Suite
3218-85, 3293-94 
 Tower B, Center of Shanghai 
 No. 100
Zunyi Road 
 Shanghai, 200051 P. R. China 
 Tel: +8621 6237 0616

 Fax: +8621 6237 1918 
 Attn: Mr. Chan Yi Sing 

 

 47 

 EXHIBIT A 
 ADHERENCE AGREEMENT 
 This Adherence Agreement (“Adherence Agreement”) is executed by the
undersigned (the “Transferee”) pursuant to the terms of that certain Shareholders’ Agreement dated as of November [...], 2006 (the “Agreement”) by and among CGEN Digital Media Company Limited,
a Cayman Islands exempted company (the “Company”) and certain of its shareholders and in consideration of the Shares subscribed for by the Transferee thereunder and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged. Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Agreement. By the execution of this Adherence Agreement, the Transferee agrees as follows:

 1. Acknowledgment. Transferee acknowledges that Transferee is acquiring [number] [Preferred/Ordinary] shares of the Company (the
“Shares”) from [name of transferor] (the “Transferor”), subject to the terms and conditions of the Agreement. 
 2. Agreement. Immediately upon transfer of the Shares, Transferee (i) agrees that the Shares acquired by Transferee shall be bound by and subject to the terms of the Agreement applicable to the Transferor,
and (ii) hereby adopts the Agreement with the same force and effect as if Transferee were originally a/an [Ordinary Shareholder thereunder (if transferor is a Ordinary Shareholder)]/[Investor thereunder (if transferor is an
Investor)]. 
 3. Notice. Any notice required or permitted by the Agreement shall be given to Transferee at the address listed
beside Transferee’s signature below. 
 EXECUTED AND DATED this ______ day of _________________, ____. 
  

			
	TRANSFEREE:
		
	By:	 	 
		
	Name:	 	 
		
	Title:	 	 
		
	Address:	 	 
		
	Fax:	 	 

  

 48 

			
	Accepted and Agreed:
	
	CGEN DIGITAL MEDIA COMPANY LIMITED
		
	By:	 	 
		
	Name:	 	 
		
	Title:	 	 

  

 49

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}]]